المؤلفون: 游晧欣, Yu, Hao-Hsin

المساهمون: 沈麗娟, 臺灣大學：藥學研究所

مصطلحات موضوعية: 一氧化氮, 神, 經毒性, 共同培養, 經細胞, 小神, 經膠質細胞, 一氧化氮合成酶, 精, 氨酸脫亞氨酶, nitric oxide, inducible nitric oxide synthase (iNOS), recombinant arginine deiminase (rADI), neurons microglia, co-culture, neurotoxicity

وصف الملف: 1389482 bytes; application/pdf

العلاقة: [1] Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 1989;3:31-6. [2] Low SY. Application of pharmaceuticals to nitric oxide. Mol Aspects Med 2005;26:97-138. [3] Vallance P, Leiper J. Blocking NO synthesis: how, where and why? Nat Rev Drug Discov 2002;1:939-50. [4] Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 1996;271:C1424-37. [5] Mungrue IN, Bredt DS. nNOS at a glance: implications for brain and brawn. J Cell Sci 2004;117:2627-9. [6] Guix FX, Uribesalgo I, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 2005;76:126-52. [7] Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357:593-615. [8] Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BSS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. PNAS 1998;95:9220-5. [9] Xia Y, Roman LJ, Masters BSS, Zweier JL. Inducible Nitric-oxide Synthase Generates Superoxide from the Reductase Domain. J Biol Chem 1998;273:22635-9. [10] Pou S, Keaton L, Surichamorn W, Rosen GM. Mechanism of Superoxide Generation by Neuronal Nitric-oxide Synthase. J Biol Chem 1999;274:9573-80. [11] Moro MA, Almeida A, Bolanos JP, Lizasoain I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med 2005;39:1291-304. [12] Warner DS, Sheng H, Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004;207:3221-31. [13] Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-61. [14] Kader A, Frazzini VI, Solomon RA, Trifiletti RR. Nitric oxide production during focal cerebral ischemia in rats. Stroke 1993;24:1709-16. [15] Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain I. Role of nitric oxide after brain ischaemia. Cell Calcium 2004;36:265-75. [16] Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 1998;57:338-42. [17] Colton CA, Vitek MP, Wink DA, Xu Q, Cantillana V, Previti ML, et al. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2006;103:12867-72. [18] Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol 2007;500:20-46. [19] Li HL, Kostulas N, Huang YM, Xiao BG, van der Meide P, Kostulas V, et al. IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. J Neuroimmunol 2001;116:5-14. [20] Eliasson MJL, Huang Z, Ferrante RJ, Sasamata M, Molliver ME, Snyder SH, et al. Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation in Ischemic Stroke Linked to Neural Damage. J Neurosci 1999;19:5910-8. [21] Endres M, Laufs U, Liao JK, Moskowitz MA. Targeting eNOS for stroke protection. Trends Neurosci 2004;27:283-9. [22] Lipton SA. Neuronal protection and destruction by NO. Cell Death Differ 1999;6:943-51. [23] Kavya R, Saluja R, Singh S, Dikshit M. Nitric oxide synthase regulation and diversity: Implications in Parkinson's disease. Nitric Oxide 2006;15:280-94. [24] Simic G, Lucassen PJ, Krsnik Z, Kruslin B, Kostovic I, Winblad B, et al. nNOS Expression in Reactive Astrocytes Correlates with Increased Cell Death Related DNA Damage in the Hippocampus and Entorhinal Cortex in Alzheimer's Disease. Exp Neurol 2000;165:12-26. [25] Soraru G, Vergani L, Fedrizzi L, D Ascenzo C, Polo A, Bernazzi B, et al. Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. Neuropathol Appl Neurobiol 2007;33:204-11. [26] Mashimo H, Goyal RK. Lessons From Genetically Engineered Animal Models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol Gastrointest Liver Physiol 1999;277:G745-50. [27] Huang ZH, Paul L; . Panahian, Nariman; Dalkara, Turgay; Fishman, Mark C.; Moskowitz, Michael A. Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase. Science 1994;265:1883-5. [28] Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 1996;16:2479-87. [29] Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene. J Neurosci 1997;17:9157-64. [30] Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, et al. Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice Are Attenuated by Nitro-l-Arginine. J Cereb Blood Flow Metab 1996;16:981-7. [31] Chiang TM, Cole F, Woo-Rasberry V, Kang ES. Role of Nitric Oxide Synthase in Collagen-Platelet Interaction: Involvement of Platelet Nonintegrin Collagen Receptor Nitrotyrosylation. Thromb Res 2001;102:343-52. [32] Holtz ML, Craddock SD, Pettigrew LC. Rapid expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain. Brain Res 2001;898:49-60. [33] Niwa M, Inao S, Takayasu M, Kawai T, Kajita Y, Nihashi T, et al. Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats. Neurol Med Chir (Tokyo) 2001;41:63-72; discussion -3. [34] Wei G, Dawson VL, Zweier JL. Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochim Biophys Acta 1999;1455:23-34. [35] Colleen F, Clark HB, Ross ME, Constantino I. Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol 1999;V97:215-20. [36] Seung U. Kim JdV. Microglia in health and disease. J Neurosci Res 2005;81:302-13. [37] Claire L. Gibson TCCSPM. Glial nitric oxide and ischemia. Glia 2005;50:417-26. [38] Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978;38:3751-7. [39] Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 1992;31:616-21. [40] Gibbons HM, Dragunow M. Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res 2006;1084:1-15. [41] Ding-Zhou L, Marchand-Verrecchia C, Croci N, Plotkine M, Margaill I. -NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice. Eur J Clin Pharmacol 2002;457:137-46. [42] Dawson DA, Kusumoto K, Graham DI, McCulloch J, Macrae IM. Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett 1992;142:151-4. [43] Zhang F, Iadecola C. Nitroprusside improves blood flow and reduces brain damage after focal ischemia. Neuroreport 1993;4:559-62. [44] Jiang MH, Kaku T, Hada J, Hayashi Y. Different effects of eNOS and nNOS inhibition on transient forebrain ischemia. Brain Res 2002;946:139-47. [45] Willmot M, Gibson C, Gray L, Murphy S, Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: A systematic review. Free Radic Biol Med 2005;39:412-25. [46] Altucci P, Sapio V, Vitale P, de Vargas F. [Mycoplasma in human pathology. Current status of the problem, with special reference to respiratory pathology]. Recenti Prog Med 1966;41:409-55. [47] Simon JP, Wargnies B, Stalon V. Control of enzyme synthesis in the arginine deiminase pathway of Streptococcus faecalis. J Bacteriol 1982;150:1085-90. [48] Baur H, Luethi E, Stalon V, Mercenier A, Haas D. Sequence analysis and expression of the arginine-deiminase and carbamate-kinase genes of Pseudomonas aeruginosa. Eur J Biochem 1989;179:53-60. [49] Fenske JD, Kenny GE. Role of arginine deiminase in growth of Mycoplasma hominis. J Bacteriol 1976;126:501-10. [50] Misawa S, Aoshima M, Takaku H, Matsumoto M, Hayashi H. High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J Biotechnol 1994;36:145-55. [51] Takaku H, Matsumoto M, Misawa S, Miyazaki K. Anti-tumor activity of arginine deiminase from Mycoplasma argini and its growth-inhibitory mechanism. Jpn J Cancer Res 1995;86:840-6. [52] Mori M, Gotoh T. Arginine Metabolic Enzymes, Nitric Oxide and Infection. J Nutr 2004;134:2820S-5. [53] Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Pegylated Arginine Deiminase (ADI-SS PEG20,000 mw) Inhibits Human Melanomas and Hepatocellular Carcinomas in Vitro and in Vivo. Cancer Res 2002;62:5443-50. [54] Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De Rosa V, et al. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol 2004;22:1815-22. [55] Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 2005;23:7660-8. [56] Dillon BJ, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit 2002;8:BR248-53. [57] Thomas JB, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin. Biochem J 2002;363:581-7. [58] Shen LJ, Lin WC, Beloussow K, Hosoya K, Terasaki T, Ann DK, et al. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem Pharmacol 2003;66:1945-52. [59] Shen LJ, Beloussow K, Shen WC. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol 2005;69:97-104. [60] Mahar Doan KM, Lakhman SS, Boje KMK. Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion technique. Brain Res 2000;876:141-7. [61] Beloussow K, Wang L, Wu J, Ann D, Shen W-C. Recombinant arginine deiminase as a potential anti-angiogenic agent. Cancer Lett 2002;183:155-62. [62] Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997;272:4959-63. [63] Babu BR, Griffith OW. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J Biol Chem 1998;273:8882-9. [64] Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-7. [65] Weissman BA, Gross SS. Current Protocol in Neuroscience. Measurement of NO and NO Synthase: John Wiley & Sons, Inc., 1998. p. 7.13.1-7.22. [66] Sambrook J, Russell DW. Molecular Cloning, A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 2001. [67] Gallagher S, Winston SE, Fuller SA, Hurrell JGR. Current protocols in Neuroscience. Immunoblotting and Immunodetection: John wiley & Sons, Inc., 2004. [68] Shen LJ, Lin WC, Beloussow K, Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett 2003;191:165-70. [69] Sugimura K, Ohno T, Fukuda S, Wada Y, Kimura T, Azuma I. Tumor Growth Inhibitory Activity of a Lymphocyte Blastogenesis Inhibitory Factor. Cancer Res 1990;50:345-9. [70] Gong H, Zolzer F, von Recklinghausen G, Rossler J, Breit S, Havers W, et al. Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem Biophys Res Commun 1999;261:10-4. [71] Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett 2002;322:121-5. [72] Braissant O, Gotoh T, Loup M, Mori M, Bachmann C. L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 1999;70:231-41. [73] Van Geldre LA, Timmermans J-P, Lefebvre RA. -Citrulline recycling by argininosuccinate synthetase and lyase in rat gastric fundus. Eur J Pharmacol 2002;455:149-60. [74] Kawahara K, Gotoh T, Oyadomari S, Kajizono M, Kuniyasu A, Ohsawa K, et al. Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells. Brain Res Mol Brain Res 2001;90:165-73. [75] Gotoh T, Mori M. Arginase II Downregulates Nitric Oxide (NO) Production and Prevents NO-mediated Apoptosis in Murine Macrophage-derived RAW 264.7; en-US; http://ntur.lib.ntu.edu.tw/handle/246246/55593Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/55593/1/ntu-96-R94423021-1.pdfTest

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/55593Test
http://ntur.lib.ntu.edu.tw/bitstream/246246/55593/1/ntu-96-R94423021-1.pdfTest

المؤلفون: 林亮宇, Lin, Lian-Yu

المساهمون: 廖朝崧, 臺灣大學：臨床醫學研究所

مصطلحات موضوعية: 一氧化氮合成酵素, 一氧化氮, 內皮細胞功能失常, 熱激蛋白, 脂泌素, 細胞凋亡, 第二型血管張力素, 高糖, 家族性高膽固醇血症, 肥胖, endothelial nitric oxide synthase, nitric oxide, endothelial cell dysfunction, heat shock protein, adiponectin, apoptosis, angiotensin II, hyperglycemia, familial hypercholesterolemia, obesity

وصف الملف: 1630294 bytes; application/pdf

العلاقة: Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72-5. Agnès B, Pierre S, Chantal D, Stéphane M, Jean-Luc B, Olivier F. Hsp90 and Caveolin Are Key Targets for the Proangiogenic Nitric Oxide–Mediated Effects of Statins. Cir Res. 2001;89:866-73. Aguilera G, Kapur S, Feuillan P, Sunar-Akbasak B, Bathia AJ. Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Int. 1994;46:973-979. Alexander RW, Dzau VJ. Vascular Biology: The Past 50 Years. Circulation 2000;102:112-6. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disrod. 1999;23:936-42. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adiponcyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105:2893-8. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein: adiponectin in obesity. Biochem Biophys Res Commun. 1999;257:79-83. Baratta R, Amato S, Degano C, Farina MG, Patane G, Vigneri R,et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 2004;89:2665-71. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High glucose-triggered apoptosis in cultured endothelial cells. Diabetes. 1995;44:1323-7. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40:405-12. Bayraktutan U. Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells. J Hypertens. 2003;21:2093-101. Bayraktutan U, Ulker S. Effects of angiotensin II on nitric oxide generation in proliferating and quiescent rat coronary microvascular endothelial cells. Hypertens Res. 2003;26:749-57. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-37. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995;38:86-96. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-53. Bhardwaj R, Moore PK. Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmcol. 1988;40:739-42. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest. 2002;32(Suppl 3):14-23. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990; 85:587-90. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285: e527-33 Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest. 1991;87:432-8. Buhler FR, Laragh JH, Baer L,et al. Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med. 1972;287:1209-14. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-4. Cai H, Li Z, Dikalov S, Holland SM, Hwang J, Jo H, et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem. 2002;277:48311-7. Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys. 1996;328:309-16. Cayette AJ, Palcino JJ, Hortens K, Cohen R. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14: 753-9. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-5. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 2005;102:9056-61. Chandran M, Ciaraldi T, Phillips SA, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26:2442-50. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021-6. Consensus Development Conference Statement. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956-61. Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter JM. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol. 1997;29:964-8. Civitarese AE, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S, et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia. 2004;47:816-20 Dagher Z, Ruderman N, Tornheim K, Ido Y. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells. Circ Res. 2001; 88:1276-82. Dagher Z, Ruderman N, Tornheim K, Ido Y. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Commun. 1999;265:112-5. Daniels SR. Cardiovascular disease risk factors and atherosclerosis in children and adolescents. Curr Atheroscler Rep. 2001;3:479-85. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 1995;26:764-70. Desideri G, De Simone M, Iughetti L, Rosato T, Iezzi ML, Marinucci MC, et al. Early activation of vascular endothelial cells and platelets in obese children. J Clin Endocrinol Metab. 2005;90:3145-52. de Man FH, Jonkers IJ, Schwedhelm E, Smelt AH, Onkenhout W, van Duyvenvoorde W, et al. Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy. Arterioscler Thromb Vasc Biol. 2000; 20:2434-40. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol. 2000; 20: 744-750. Dikalov S, Landmesser U, Harrison DG. Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitric-oxide synthase. J Biol Chem. 2002;277:25480-5. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells: protective effect of nitric oxide. Cir Res. 1997;81:970-6. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J Exp Med. 1997;185:601–608. Dolgov VV, Zaikina OE, Bondarenko MF, Repin VS. Aortic endothelium of alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia. 1982; 22:338-43. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension. 2001;37:554-60. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis. 1997;39:287–324. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 2001 ;108:1341-8. d'Uscio LV, Smith LA, Katusic ZS. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice. Stroke. 2001;32:2658–64. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. (2001) Adiponectin gene expression is inhibited by beta adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS lett. 2001;507:142-6. Fenster CP, Darley-Usmar VM, Landar AL, Gower BA, Weinsier RL, Hunter GR, et al. Weight loss and race modulate nitric oxide metabolism in overweight women. Free Radic Biol Med. 2004;37:695-702. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest. 1999;103:897-905. Fleming I, Bauersachs J, Fisslthaler B, Busse R. Calcium-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res. 1998;82:686-95. Francesco C, Keiichi H, Zvonimir SK, Thomas FL. High Glucose Increases Nitric Oxide Synthase Expression and Superoxide Anion Generation in Human Aortic Endothelial Cells. Circulation 1997;96:25-8. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001;98:2005-10. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597-601. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999;38:202–6. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-6. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998;392:821-4. Garcia-Cardena G, Fan R, Stern DF, Liu J, Sessa WC. Endothelial nitric oxide is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem. 1996;271,27237-40. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994; 330: 1431-8. Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutri. 2004;23:963-74. Goldstein BJ, Scalia R. Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function. Journal of Clinical Endocrinology & Metabolism. 2004;89:2563-8. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol. 1996;36:281-306. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle: new concepts. Hypertension. 1997; 29:366-73. Gunnett, Heistad DD, Faraci FM: Gene targeted mice reveal a critical role for inducible nitric oxide synthase in vascular dysfunction during diabetes. Stroke. 2003;34:2970 -4. Gunnett CA, Lund DD, Chu Y, Brooks RM II, Faraci FM, Heistad DD: Nitric oxide dependent vasorelaxation is impaired after gene transfer of inducible NO synthase. Arterioscler Thromb Vasc Biol. 2001;21:1281-7. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997;20:1087-92. Hayashi T, Sumi D, Juliet PA, Matsui-Hirai H, Asai-Tanaka Y, Kano H, et al. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rat. Cardiovasc Res. 2004;61:339-51. Heart Protection Study Collaborative Group. 2003. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 individuals with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-16. Hegele RA. Environmental modulation of atherosclerosis end points in familial hypercholesterolemia. Atheroscler Suppl. 2002;2:5-7. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Sasaki S, et al. Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. J Am Coll Cardiol. 2003;42:256-63. Hirata K, Akita H, Yokoyama M. Oxidized low density lipoprotein inhibits bradykinin-induced phosphoinositide hydrolysis in cultured bovine aortic endothelial cells. FEBS Lett. 1991;287:181-4. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY. High Glucose–Induced Apoptosis in Human Endothelial Cells Is Mediated by Sequential Activations of c-Jun NH2-Terminal Kinase and Caspase-3. Circulation. 2000;101:2618-24 Ho FM, Liu SH, Liau CS, Huang PJ, Shiah SG, Lin-Shiau SY. Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage. J Cell Biochem. 1999;75:258-63. Holven KB, Myhre AM, Aukrust P, Hagve TA, Ose L, Nenseter MS. Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender. Eur Heart J. 2003;24:1756-62. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595-9. Houben AJHM, Schaper NC, Slaaf DW, Tangelder GJ, Nieuwenhuijzen Kruseman AC. Skin blood cell flux in insulin-dependent diabetic subjects in relation to retinopathy or incipient nephropathy. Eur J Clin Invest. 1992;22:67-72. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748–50. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, et al. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension. 1998; 31:342-8. Inoue N, Hirata K, Yamada M, Hamamori Y, Matsuda Y, Akita H, et al. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res. 1992;71:1410–21. Jaffe EA, Nachman RI, Becker CG, Minick RC. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52:2745-6. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 1998;54:775-84. Jonkers IJ, van de Ree MA, Smelt AH, de Man FH, Jansen H, Meinders AE, et al. Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia. Cardiovasc Res. 2002;53:496-501. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, et al. Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults : The Cardiovascular Risk in Young Finns Study. Circulation. 2004;110:2918-23. Kanazawa K, Kawashima S, Mikami S, Miwa Y, Hirata K, Suematsu M, et al. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol. 1996;148:1949–1956. Kashiwagi M, Shinozaki M, Hirakata H, Tamaki K, Hirano T, Tokumoto M, et al. Locally activated renin-angiotensin system associated with TGF-[beta]1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol. 2000;11:616-24. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:998-1005. Ketteler M, Noble NA, Border WA. Transforming growth factor-[beta] and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol. 1995;57:279-95. Klein S, Burke LE, Bray GA, Blair SPED, Allison DB, Pi-Sunyer X, et al. Clinical implications of obesity with specific focus on cardiovascular disease: A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2004;110:2952-67. Kobayashi H, Ouchi N, Kihara S, Walsh K, Dumada M, Abe Y, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight from of adiponectin. Circ Res. 2004;94:e27-31. Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol. 1970;69:403-14. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-43. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277:25863-6. Kupatt C, Dessy C, Hinkel R, Raake P, Daneau G, Bouzin C, et al. Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation. Arterioscler Thromb Vasc Biol. 2004;24:1435-41. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675-87. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. 1994. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960-7. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003;278:22546-54. Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, et al. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest. 1998;101:1156-62. Lee WJ, Chen HH, Wang W, Wei PL, Lin CM, Huang MT. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459-64. Leopoldo R. Hypertension and Cardiovascular Risk Factors: Role of the Angiotensin II–Nitric Oxide Interaction. Hypertension. 2001;37(Suppl):S767-73. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res. 1999;84:1043–1049. Lihn AS, Richelsen B, Pedersen SB, Haugaard SB, Rathje GS, Madsbad S, et al. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab. 2003;285:E1072-80. Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes. 1991;40:653-9. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture. Diabetes. 1985; 34:621-7. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-51. Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266-3268. Lu G, Greene EL, Nagai T, Egan BM. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 1998;32:1003-10. Lundman P, Tornvall P, Nilsson L, Pernow J. A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis. 2001;159:35-41. Marrero MB, Venema VJ, Ju H, He H, Liang H, Caldwell, et al. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J. 1999;343,335-40. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 2002; 87,2764-9. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487-91. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and Metabolic Syndrome. Arteriosclerosis, Thrombosis & Vascular Biology. 2004;24:29-33. Maxwell AJ, Cooke JP. The role of nitric oxide in atherosclerosis. Coron Artery Dis. 1999;10:277-86. Meraji S, Jayakody L, Senaratne MP, Thomson AB, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes. 1987;36:978-81. Michel JB, Feron O, Sacks D, Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem. 1997;272:15583-6. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999;99:1141–16. Mizia-Stec K, Zahorska-Markiewicz B, Mandecki T, Janowska J, Szulc A, Jastrzekbska-Maj E, et al. Hyperlipidaemias and serum cytokines in patients with coronary artery disease. Acta Cardiol. 2003;58,9-15. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest. 1971;28:91-100. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90:E58-65. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52:1270-5. Monti LD, Landoni C, Setola E, Galluccio E, Lucotti P, Sandoli EP, et al. Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. Am J Physiol Heart Circ Physiol. 2004;287:H1225-31. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem. 1995;41:892-6. Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun. 2004;315:264–271. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dis-mutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69:1293–300. Murray P, Pitt B, Webb RC. Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia. 1994;37:664-70. Naftilan AJ, Pratt RE, Dzau VJ. Induction of PDGF A-chain and c-myc gene expressions by angiotensin II in vascular smooth muscle cells. J Clin Invest. 1989;83:1419-24. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol. 2005;289:H2144-52. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;2417-23. National Diabetes Data Group. Diabetes in America. 2nd edition. National Institute of Diabetes and Digestive and Kidney Diseases. NIH publication 1995;782 pp:95-1468. Noronha BT, Li JM, Wheatcroft SB, Shah AM, Kearney MT. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 2005;54:1082-9. Ohashi H, Takagi H, Oh H, Suzuma K, Suzuma I, Miyamoto N, et al. Phosphatidylinositol 3-Kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 Activity. Circ Res. 2004;94:785 Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767-70. Ono H, Umeda F, Inoguchi T, Ibayashi H. Glucose inhibits prostacyclin production by cultured aortic endothelial cells. Thromb Haemost. 1988;60:174-7. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103:1057-63. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004;279:1304-9. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules; Adipocyte-derived plasma protein, adiponectin. Circulation. 1999;100:2473-6. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 1986 ;132:75-8. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, et al. Biological aspects of reactive nitrogen speces. Biochim Biophys Acta. 1999;1411;385-400. Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol. 1997;29:8-15. Pieper GM, Dondlinger LA. Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharmacol Exp Ther. 1997;283:684-91. Pieper GM. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 1999;42:204-13. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, Michel T. Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem. 1998;273:27383–8. Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawin MA, et al. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation. 2000;101:2349-54. Pratt WB. The role of the Hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 1997;37:297-326. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, et al. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem. 2001;276:17621-4. Raal FJ, Panz VR, Pilcher GJ, Joffe BI. Atherosclerosis seems not to be associated with hyperinsulinaemia in patients with familial hypercholesterolaemia. J Intern Med. 1999;246:75-80. Raij L, Hayakawa H, Jaimes EA. Cardio-renal injury and nitric oxide synthase activity in hypertension. J Hypertens. 1998;16(suppl 8):S69-73. Raitakari M, Ilvonen T, Ahotupa M, Lehtimaki T, Harmoinen A, Suominen P, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004;24:124-8. Rakhit, R D, Marber M S. Nitric oxide: an emerging role in cardioprotection? Heart. 2001;86:368-72. Reilly JJ, Dorosty AR, Emmett PM. Prevalence of overweight and obesity in British children: cohort study. Br Med J. 1999;319:1039. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 2002;106:2530-2. Roberts CK, Vaziri ND, Wang XQ, Barnard RJ. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension. 2000;36:423-9. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol. 1977; 86: 675-84. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003;14:447-55. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101:731-6. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J Biol Chem. 2000;275:5026-30. Sampietro T, Tuoni M, Ferdeghini M, Ciardi A, Marraccini P, Prontera C, et al. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 1997;96:1381-5. Sandeman DD, Shore AC, Tooke JE. 1996. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med. 1996;327:760-4. Schiffrin EL. State-of-the-art lecture: role of endothelin-1 in hypertension. Hypertension. 1999;34:876-81. Shi Y. Baker JE. Zhang C. Tweddell JS. Su J. Pritchard KA Jr. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circulation Research. 2002;91:300-6. Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, et al. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2-imbalance in insulin-resistant rat aorta. Diabetes. 1999;48:2437-45. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med. 2004;37:115-23. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601-10. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100:1230-9. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 1997;99:278-87. Taku T, Toshio H, Hatsuyo K, Daigo S, Hisako MH, Navin KT, et al. Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days. Circulation. 2001;04:376-9. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 2004;89:765-9. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med. 1994;16:383-91. Tesfamariam B, Jakubowski JA, Cohen RA. Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol. 1989;257:H1327-33. The Diabetes Control, and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86. Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH Publication 2002:2-5215. National Heart, Lung, and Blood Institute, National Institutes of Health Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, et al. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rat by aldose reductase inhibitors. Diabetes. 1989;38:1258-70. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22-8. Tomasz JG, Shafi MM, Daniela G, Jerzy S, Chandi R, Ravi P, et al. Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase. Circulation. 2002;105:1656-62. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001;358:1400–4. Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML. The contrasting roles of ICE family proteases and interleukin-1ß in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down regulation. Proc Natl Acad Sci U S A. 1996;93:5635–40. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278: 50810-7. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. New Engl J Med 1981; 304: 930-933. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest. 1996;56:577-81. Virkola K, Pesonen E, Akerblom HK, Siimes MA. Cholesterol and carotid artery wall in children and adolescents with famililar hypercholesterolemia: a controlled study by ultrasound. Acta Pediatr. 1997;86:1203-7. Wakabayashi I, Hatake K, Kimura N, Kaksishita E, Nagai K. Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci. 1987;40:643-8. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278:40352-63. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology. 2005;146:790–796 Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17:3147-53. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M,et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999;99:2027–33. Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension. 2005;45:163-9. Wever RM, van Dam T, van Rijn HJ, de Groot F, Rabelink TJ. Tetra-hydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun. 1997;237:340–4. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium : mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord. 2002;26:754-64. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567-74. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complication. Diabetes. 1993;42:801-13. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 1994;91:1044-8. White RE, Carrier GO. Supersensitivity and endothelium dependency of histamine-induced relaxation in mesenteric arteries isolated from diabetic rats. Pharmocology. 1986;33:34-38. Wolff SP, Dean RT. Glucose autoxidation and protein modification: the potential role of oxidative glycosylation in diabetes. Biochem J. 1998;245:243-50. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430-42. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obesity. 2004;28:852-7. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7: 941-6. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423:726-9. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978. Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest. 2004;125:823-30.; zh-TW; http://ntur.lib.ntu.edu.tw/handle/246246/55516Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/55516/1/ntu-94-D90421003-1.pdfTest

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/55516Test
http://ntur.lib.ntu.edu.tw/bitstream/246246/55516/1/ntu-94-D90421003-1.pdfTest

المؤلفون: Yang, Yi-Lin, Hwu, Jenn-Gwo

المساهمون: National Taiwan University Dept Elect Engn

المصدر: http://ieeexplore.ieee.orgTest/.

مصطلحات موضوعية: Metal–oxide–semiconductor (MOS), scanning frequency anodization (SF ANO), ultrathin gate oxide

وصف الملف: application/pdf; 136932 bytes

العلاقة: IEEE ELECTRON DEVICE LETTERS, VOL. 25, NO. 10, OCTOBER 2004; 246246/200611150121591; http://ntur.lib.ntu.edu.tw/handle/246246/200611150121591Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/200611150121591/1/4694.pdfTest

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/200611150121591Test
http://ntur.lib.ntu.edu.tw/bitstream/246246/200611150121591/1/4694.pdfTest

المؤلفون: 呂宗昕, 王憲程

المساهمون: 國立臺灣大學化學工程研究所

مصطلحات موضوعية: lithium-ion secondary batteries, lithium cobalt oxide, lithium nickel oxide, lithium manganese oxide, nanotechnology

وصف الملف: application/pdf; 1437592 bytes

العلاقة: 國立臺灣大學「臺大工程」學刊 84, 129-135; 246246/2006121215551154; http://ntur.lib.ntu.edu.tw/handle/246246/2006121215551154Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/2006121215551154/1/1160018431707560374351.pdfTest

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/2006121215551154Test
http://ntur.lib.ntu.edu.tw/bitstream/246246/2006121215551154/1/1160018431707560374351.pdfTest

المؤلفون: 鄒粹軍, 葉斯清, 蔡峰源, 林合真, 鄭尊仁, 趙浩然, 戴麟靄, TSOU, TSUI-CHUN, YEH, SZU-CHING, TSAI, FENG-YUAN, LIN, HO-JANE, CHENG, TSUN-JEN, CHAO, HOW-RAN, TAI, LIN-AI

المساهمون: 職醫與工衛所

مصطلحات موضوعية: Zinc oxide, Endothelium, Inflammation, NF-kappa B, Adhesion molecules, Cytokines

العلاقة: JOURNAL OF HAZARDOUS MATERIALS v.183 n.1-3 pp.182-188; http://ntur.lib.ntu.edu.tw/handle/246246/235898Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/235898Test

المؤلفون: 鄭志鴻, 陳健尉, 施能朗, 林家瑋, 劉如濟, 陳燕玲, 陳正憲, 陳錦澤, CHENG, TZU-HURNG, CHEN JEREMY J. W., SHIH, NENG-LANG, LIN, JIA-WEI, LIU, JU-CHI, CHEN, YEN-LING, CHEN, CHENG-HSIEN, CHEN, JIN-JER

المساهمون: 內科

مصطلحات موضوعية: cardiomyocytes, cDNA microarray, endothelial nitric oxide synthase, mechanical stretch

العلاقة: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY v.36 n.5-6 pp. 559-566; http://ntur.lib.ntu.edu.tw/handle/246246/188613Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/188613Test

المؤلفون: 謝國煌, 廖肯萱, 賴向華, 李伯訓, 李仲毅, 林俊彬, HSIEH, KUO-HUANG, LIAO, KEN-HSUAN, LAI, EDDIE HSIANG-HUA, LEE, BOR-SHIUNN, LEE, CHUNG-YI, LIN, CHUN-PIN

المساهمون: 牙醫學系所

مصطلحات موضوعية: mechanical property, root canal obturation, thermal property, zinc oxide/thermoplastic polyurethane composite

العلاقة: JOURNAL OF ENDODONTICS v.34 n.3 pp.303-305; http://ntur.lib.ntu.edu.tw/handle/246246/174544Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/174544Test

المؤلفون: 卜令柟, 張美惠, 倪衍玄, 陳慧玲, 鄭嘉琪, BU, LING-NAN, CHANG, MEI-HWEI, NI, YEN-HSUAN, CHEN, HUE-LING, CHENG, CHIA-CHI

المساهمون: 小兒科

مصطلحات موضوعية: children, constipation, Lactobacillus casei rhamnosus, Lcr35, magnesium oxide, probiotics

العلاقة: PEDIATRICS INTERNATIONAL v.49 n.4 pp.485-490; http://ntur.lib.ntu.edu.tw/handle/246246/88799Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/88799Test

المؤلفون: 翁德怡, Weng, Te-I

المساهمون: 劉興華, 臺灣大學：毒理學研究所

مصطلحات موضوعية: 大腸桿菌, 膀胱感染, Uropathogenic Escherichia coli, lipopolysaccharide, bladder, contraction, inducible nitric oxide synthase, protein kinase C, extracellular signal-regulated kinase (ERK)

وصف الملف: 1248911 bytes; application/pdf

العلاقة: Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., van Kerrebroeck, P., Victor, A., and Wein, A. (2002). The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21, 167-178. Abrutyn, E., Mossey, J., Berlin, J. A., Boscia, J., Levison, M., Pitsakis, P., and Kaye, D. (1994). Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 120, 827-833. Adam, L. P., Franklin, M. T., Raff, G. J., and Hathaway, D. R. (1995). Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res 76, 183-190. Al-Waili, N. S., Al-Waili, T. N., Al-Waili, A. N., and Saloom, K. Y. (2005). Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories. World J Urol 23, 287-294. Alexander, R. S. (1973). Viscoplasticity of smooth muscle of urinary bladder. Am J Physiol 224, 618-622. Ambache, N., and Zar, M. A. (1970). Non-cholinergic transmission by post-ganglionic motor neurones in the mammalian bladder. J Physiol 210, 761-783. Anderson, K. E. (1993). Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45, 253-308. Andersson, K. E., and Arner, A. (2004). Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84, 935-986. Andersson, K. E., Garcia Pascual, A., Forman, A., and Tottrup, A. (1991). Non-adrenergic, non-cholinergic nerve-mediated relaxation of rabbit urethra is caused by nitric oxide. Acta Physiol Scand 141, 133-134. Andersson, K. E., Garcia Pascual, A., Persson, K., Forman, A., and Tottrup, A. (1992). Electrically-induced, nerve-mediated relaxation of rabbit urethra involves nitric oxide. J Urol 147, 253-259. Andersson, K. E., and Persson, K. (1994). Nitric oxide synthase and nitric oxide-mediated effects in lower urinary tract smooth muscles. World J Urol 12, 274-280. Andersson, K. E., and Persson, K. (1995). Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology. Scand J Urol Nephrol Suppl 175, 43-53. Ansari, H. R., Husain, S., and Abdel-Latif, A. A. (2001). Activation of p42/p44 mitogen-activated protein kinase and contraction by prostaglandin F2alpha, ionomycin, and thapsigargin in cat iris sphincter smooth muscle: inhibition by PD98059, KN-93, and isoproterenol. J Pharmacol Exp Ther 299, 178-186. Apostolidis, A. N., Yiangou, Y., Brady, C. M., Ford, A. P., Baecker, P. A., Jacques, T. S., Freeman, A., Fowler, C. J., and Anand, P. (2004). Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin. BJU Int 93, 336-340. Arner, A., and Hellstrand, P. (1983). Activation of contraction and ATPase activity in intact and chemically skinned smooth muscle of rat portal vein. Dependence on Ca++ and muscle length. Circ Res 53, 695-702. Asscher, A. W., Sussman, M., Waters, W. E., Davis, R. H., and Chick, S. (1966). Urine as a medium for bacterial growth. Lancet 2, 1037-1041. Bagshaw, S. M., and Laupland, K. B. (2006). Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis 19, 67-71. Barnett, B. J., and Stephens, D. S. (1997). Urinary tract infection: an overview. Am J Med Sci 314, 245-249. Bass, P. F., 3rd, Jarvis, J. A., and Mitchell, C. K. (2003). Urinary tract infections. Prim Care 30, 41-61, v-vi. Bayliss, M., Wu, C., Newgreen, D., Mundy, A. R., and Fry, C. H. (1999). A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 162, 1833-1839. Beshay, E., and Carrier, S. (2004). Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 64, 1062-1067. Bolton, T. B., Prestwich, S. A., Zholos, A. V., and Gordienko, D. V. (1999). Excitation-contraction coupling in gastrointestinal and other smooth muscles. Annu Rev Physiol 61, 85-115. Brading, A. F. (2002). The sarcoplasmic reticulum in disease and smooth muscle dysfunction: therapeutic potential. Novartis Found Symp 246, 244-254; discussion 254-247, 272-246. Bridgewater, M., MacNeil, H. F., and Brading, A. F. (1993). Regulation of tone in pig urethral smooth muscle. J Urol 150, 223-228. Bright, R., and Mochly-Rosen, D. (2005). The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 36, 2781-2790. Brown, J. S., Seeley, D. G., Fong, J., Black, D. M., Ensrud, K. E., and Grady, D. (1996). Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol 87, 715-721. Burnett, A. L., Calvin, D. C., Chamness, S. L., Liu, J. X., Nelson, R. J., Klein, S. L., Dawson, V. L., Dawson, T. M., and Snyder, S. H. (1997). Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nat Med 3, 571-574. Burnstock, G., and Williams, M. (2000). P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295, 862-869. Callahan, S. M., and Creed, K. E. (1981). Electrical and mechanical activity of the isolated lower urinary tract of the guinea-pig. Br J Pharmacol 74, 353-358. Chen, M., Bao, W., Aizman, R., Huang, P., Aspevall, O., Gustafsson, L. E., Ceccatelli, S., and Celsi, G. (2004). Activation of extracellular signal-regulated kinase mediates apoptosis induced by uropathogenic Escherichia coli toxins via nitric oxide synthase: protective role of heme oxygenase-1. J Infect Dis 190, 127-135. Chen, M., Jahnukainen, T., Bao, W., Dare, E., Ceccatelli, S., and Celsi, G. (2003). Uropathogenic Escherichia coli toxins induce caspase-independent apoptosis in renal proximal tubular cells via ERK signaling. Am J Nephrol 23, 140-151. Chess-Williams, R. (2002). Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 22, 133-145. Cohen, P. (1989). The structure and regulation of protein phosphatases. Annu Rev Biochem 58, 453-508. Colgan, R., Nicolle, L. E., McGlone, A., and Hooton, T. M. (2006). Asymptomatic bacteriuria in adults. Am Fam Physician 74, 985-990. Connell, H., Hedlund, M., Agace, W., and Svanborg, C. (1997). Bacterial attachment to uro-epithelial cells: mechanisms and consequences. Adv Dent Res 11, 50-58. Cooke, J. P., and Dzau, V. J. (1997). Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48, 489-509. Coolsaet, B. L., van Mastrigt, R., van Duyl, W. A., and Huygen, R. E. (1976). Viscoelastic properties of bladder wall strips at constant elongation. Invest Urol 13, 435-440. Creed, K. E. (1971). Membrane properties of the smooth muscle membrane of the guinea-pig urinary bladder. Pflugers Arch 326, 115-126. Creed, K. E., Ishikawa, S., and Ito, Y. (1983). Electrical and mechanical activity recorded from rabbit urinary bladder in response to nerve stimulation. J Physiol 338, 149-164. Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., and Tilton, R. G. (1994). Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93, 2684-2690. Daigle, F., Harel, J., Fairbrother, J. M., and Lebel, P. (1994). Expression and detection of pap-, sfa-, and afa-encoded fimbrial adhesin systems among uropathogenic Escherichia coli. Can J Microbiol 40, 286-291. Damaser, M. S. (1999). Whole bladder mechanics during filling. Scand J Urol Nephrol Suppl 201, 51-58; discussion 76-102. Daneshgari, F., Liu, G., and Imrey, P. B. (2006). Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol 176, 380-386. Davis, M. J., and Hill, M. A. (1999). Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79, 387-423. Davis, M. J., Wu, X., Nurkiewicz, T. R., Kawasaki, J., Davis, G. E., Hill, M. A., and Meininger, G. A. (2001). Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol 280, H1427-1433. Desai, K. M., Sessa, W. C., and Vane, J. R. (1991). Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351, 477-479. Dessy, C., Kim, I., Sougnez, C. L., Laporte, R., and Morgan, K. G. (1998). A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation. Am J Physiol 275, C1081-1086. Dokita, S., Morgan, W. R., Wheeler, M. A., Yoshida, M., Latifpour, J., and Weiss, R. M. (1991). NG-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscle. Life Sci 48, 2429-2436. Dokita, S., Smith, S. D., Nishimoto, T., Wheeler, M. A., and Weiss, R. M. (1994). Involvement of nitric oxide and cyclic GMP in rabbit urethral relaxation. Eur J Pharmacol 266, 269-275. Eglen, R. M., Hegde, S. S., and Watson, N. (1996). Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48, 531-565. Ehren, I., Adolfsson, J., and Wiklund, N. P. (1994a). Nitric oxide synthase activity in the human urogenital tract. Urol Res 22, 287-290. Ehren, I., Iversen, H., Jansson, O., Adolfsson, J., and Wiklund, N. P. (1994b). Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses. Urology 44, 683-687. Eika, B., Levin, R. M., and Longhurst, P. A. (1994). Comparison of urinary bladder function in rats with hereditary diabetes insipidus, streptozotocin-induced diabetes mellitus, and nondiabetic osmotic diuresis. J Urol 151, 496-502. Ellenberg, M. (1980). Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92, 321-323. Elliott, T. S., Reed, L., Slack, R. C., and Bishop, M. C. (1985). Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect 11, 191-199. Eto, M., Kitazawa, T., Yazawa, M., Mukai, H., Ono, Y., and Brautigan, D. L. (2001). Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem 276, 29072-29078. Felsen, D., Dardashti, K., Ostad, M., Lemer, M. L., Gross, S. S., Chen, J., Vaughan, E. D., Jr., and Poppas, D. P. (2003). Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. J Urol 169, 1569-1572. Fihn, S. D. (2003). Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 349, 259-266. Finkbeiner, A. E., and O'Donnell, P. D. (1990). Responses of detrusor smooth muscle to stretch and relaxation: in vitro study. Urology 36, 193-198. Forstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., and Kleinert, H. (1994). Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23, 1121-1131. Fowler, J. E., Jr., Latta, R., and Stamey, T. A. (1977). Studies of introital colonization in women with recurrent urinary infections. VIII. The role of bacterial interference. J Urol 118, 296-298. Foxman, B. (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113 Suppl 1A, 5S-13S. Foxman, B., Barlow, R., D'Arcy, H., Gillespie, B., and Sobel, J. D. (2000). Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10, 509-515. Foxman, B., and Brown, P. (2003). Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 17, 227-241. Freeman, B. (1994). Free radical chemistry of nitric oxide. Looking at the dark side. Chest 105, 79S-84S. Frimodt-Moller, C. (1980). Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 92, 318-321. Funfstuck, R., Franke, S., Hellberg, M., Ott, U., Knofel, B., Straube, E., Sommer, M., and Hacker, J. (2001). Secretion of cytokines by uroepithelial cells stimulated by Escherichia coli and Citrobacter spp. Int J Antimicrob Agents 17, 253-258. Funfstuck, R., Ott, U., and Naber, K. G. (2006). The interaction of urinary tract infection and renal insufficiency. Int J Antimicrob Agents 28 Suppl 1, S72-77. Funfstuck, R., Smith, J. W., Tschape, H., and Stein, G. (1997). Pathogenetic aspects of uncomplicated urinary tract infection: recent advances. Clin Nephrol 47, 13-18. Funfstuck, R., Tschape, H., Stein, G., Vollandt, R., and Schneider, S. (1989). Virulence of Escherichia coli strains in relation to their hemolysin formation, mannose-resistant hemagglutination, hydroxamate production, K 1-antigen and the plasmid profile in patients with chronic pyelonephritis. Clin Nephrol 32, 178-184. Furchgott, R. F., and Zawadzki, J. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376. Gallagher, P. J., Herring, B. P., and Stull, J. T. (1997). Myosin light chain kinases. J Muscle Res Cell Motil 18, 1-16. Ganitkevich, V., Hasse, V., and Pfitzer, G. (2002). Ca2+-dependent and Ca2+-independent regulation of smooth muscle contraction. J Muscle Res Cell Motil 23, 47-52. Garofalo, C. K., Hooton, T. M., Martin, S. M., Stamm, W. E., Palermo, J. J., Gordon, J. I., and Hultgren, S. J. (2007). Escherichia coli from Urine of Female Patients with Urinary Tract Infections Is Competent for Intracellular Bacterial Community Formation. Infect Immun 75, 52-60. Geerlings, S. E., Meiland, R., van Lith, E. C., Brouwer, E. C., Gaastra, W., and Hoepelman, A. I. (2002). Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 25, 1405-1409. Geerlings, S. E., Stolk, R. P., Camps, M. J., Netten, P. M., Collet, J. T., Schneeberger, P. M., and Hoepelman, A. I. (2001). Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 161, 1421-1427. Gerthoffer, W. T. (2005). Signal-transduction pathways that regulate visceral smooth muscle function. III. Coupling of muscarinic receptors to signaling kinases and effector proteins in gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol 288, G849-853. Gerthoffer, W. T., Yamboliev, I. A., Pohl, J., Haynes, R., Dang, S., and McHugh, J. (1997). Activation of MAP kinases in airway smooth muscle. Am J Physiol 272, L244-252. Gillespie, J. S., Liu, X. R., and Martin, W. (1989). The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br J Pharmacol 98, 1080-1082. Goeckeler, Z. M., Masaracchia, R. A., Zeng, Q., Chew, T. L., Gallagher, P., and Wysolmerski, R. B. (2000). Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 275, 18366-18374. Gorenne, I., Su, X., and Moreland, R. S. (1998). Inhibition of p42 and p44 MAP kinase does not alter smooth muscle contraction in swine carotid artery. Am J Physiol 275, H131-138. Griffith, T. M., Edwards, D. H., Newby, A. C., Lewis, M. J., and Henderson, A. H. (1986). Production of endothelium derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium. Cardiovasc Res 20, 7-12. Gupta, K., Hooton, T. M., and Stamm, W. E. (2001). Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135, 41-50. Hai, C. M. (1991). Length-dependent myosin phosphorylation and contraction of arterial smooth muscle. Pflugers Arch 418, 564-571. Harder, D. R. (1984). Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res 55, 197-202. Hartshorne, D. J., Ito, M., and Erdodi, F. (1998). Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 19, 325-341. Harvey, R. A., Skennerton, D. E., Newgreen, D., and Fry, C. H. (2002). The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J Urol 168, 1235-1239. Hashitani, H., Bramich, N. J., and Hirst, G. D. (2000). Mechanisms of excitatory neuromuscular transmission in the guinea-pig urinary bladder. J Physiol 524 Pt 2, 565-579. Hegde, S. S., and Eglen, R. M. (1999). Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci 64, 419-428. Hicks, R. M. (1975). The mammalian urinary bladder: an accommodating organ. Biol Rev Camb Philos Soc 50, 215-246. Hill, M. A., Zou, H., Potocnik, S. J., Meininger, G. A., and Davis, M. J. (2001). Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity. J Appl Physiol 91, 973-983. Hooton, T. M., Besser, R., Foxman, B., Fritsche, T. R., and Nicolle, L. E. (2004). Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 39, 75-80. Hooton, T. M., and Stamm, W. E. (1997). Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11, 551-581. Horowitz, A., Menice, C. B., Laporte, R., and Morgan, K. G. (1996). Mechanisms of smooth muscle contraction. Physiol Rev 76, 967-1003. Hu, K. K., Boyko, E. J., Scholes, D., Normand, E., Chen, C. L., Grafton, J., and Fihn, S. D. (2004). Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 164, 989-993. Huang, E. S., and Stafford, R. S. (2002). National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 162, 41-47. Igawa, Y., Mattiasson, A., and Andersson, K. E. (1993). Functional importance of cholinergic and purinergic neurotransmission for micturition contraction in the normal, unanaesthetized rat. Br J Pharmacol 109, 473-479. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84, 9265-9269. Ishihata, A., Tasaki, K., and Katano, Y. (2002). Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 445, 247-256. Iyengar, R., Stuehr, D. J., and Marletta, M. A. (1987). Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci U S A 84, 6369-6373. James, M. J., Birmingham, A. T., and Hill, S. J. (1993). Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. Br J Clin Pharmacol 35, 366-372. Jellheden, B., Norrby, R. S., and Sandberg, T. (1996). Symptomatic urinary tract infection in women in primary health care. Bacteriological, clinical and diagnostic aspects in relation to host response to infection. Scand J Prim Health Care 14, 122-128. Johansson, R., Pandita, R. K., Poljakovic, M., Garcia-Pascual, A., De Vente, J., and Persson, K. (2002a). Activity and expression of nitric oxide synthase in the hypertrophied rat bladder and the effect of nitric oxide on bladder smooth muscle growth. J Urol 168, 2689-2694. Johansson, R. K., Poljakovic, M., Andersson, K. E., and Persson, K. (2002b). Expression of nitric oxide synthase in bladder smooth muscle cells: regulation by cytokines and L-arginine. J Urol 168, 2280-2285. Johnson, G. L., and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912. Johnson, J. R. (1991). Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4, 80-128. Kaneda, T., Shimizu, K., Nakajyo, S., and Urakawa, N. (1995). Effect of phorbol ester, 12-deoxyphorbol 13-isobutylate (DPB), on muscle tension and cytosolic Ca2+ in rat anococcygeus muscle. Jpn J Pharmacol 69, 195-204. Kang, W. S., Tamarkin, F. J., Wheeler, M. A., and Weiss, R. M. (2004). Rapid up-regulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation. J Pharmacol Exp Ther 310, 452-458. Kaplan, S. A., Te, A. E., and Blaivas, J. G. (1995). Urodynamic findings in patients with diabetic cystopathy. J Urol 153, 342-344. Keith, B. R., Maurer, L., Spears, P. A., and Orndorff, P. E. (1986). Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli. Infect Immun 53, 693-696. Khakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North, R. A., Seguela, P., Voigt, M., and Humphrey, P. P. (2001). International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53, 107-118. Khan, T. A., Bianchi, C., Ruel, M., Voisine, P., Li, J., Liddicoat, J. R., and Sellke, F. W. (2003). Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone. Circulation 108 Suppl 1, II348-353. Kibbe, M. R., Li, J., Nie, S., Watkins, S. C., Lizonova, A., Kovesdi, I., Simmons, R. L., Billiar, T. R., and Tzeng, E. (2000). Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31, 1214-1228. Kinder, R. B., and Mundy, A. R. (1985). Atropine blockade of nerve-mediated stimulation of the human detrusor. Br J Urol 57, 418-421. Kobayashi, N., Horinaka, S., Mita, S., Yoshida, K., Honda, T., Kobayashi, T., Hara, K., Nishikimi, T., and Matsuoka, H. (2002). Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats. J Hypertens 20, 2475-2485. Koch, A., Nasuhara, Y., Barnes, P. J., Lindsay, M. A., and Giembycz, M. A. (2000). Extracellular signal-regulated kinase 1/2 control Ca(2+)-independent force development in histamine-stimulated bovine tracheal smooth muscle. Br J Pharmacol 131, 981-989. Kondo, A., and Susset, J. G. (1973). Physical properties of the urinary detrusor muscle. A mechanical model based upon the analysis of stress relaxation curve. J Biomech 6, 141-151. Korhonen, T. K., Virkola, R., Westerlund, B., Tarkkanen, A. M., Lahteenmaki, K., Sareneva, T., Parkkinen, J., Kuusela, P., and Holthofer, H. (1988). Tissue interactions of Escherichia coli adhesins. Antonie Van Leeuwenhoek 54, 411-420. Kotlikoff, M. I., Herrera, G., and Nelson, M. T. (1999). Calcium permeant ion channels in smooth muscle. Rev Physiol Biochem Pharmacol 134, 147-199. Kudlacz, E. M., Gerald, M. C., and Wallace, L. J. (1989). Effects of diabetes and diuresis on contraction and relaxation mechanisms in rat urinary bladder. Diabetes 38, 278-284. Kunin, C. M. (1994). Urinary tract infections in females. Clin Infect Dis 18, 1-10; quiz 11-12. Kushida, N., Kabuyama, Y., Yamaguchi, O., and Homma, Y. (2001). Essential role for extracellular Ca(2+) in JNK activation by mechanical stretch in bladder smooth muscle cells. Am J Physiol Cell Physiol 281, C1165-1172. Laher, I., and Bevan, J. A. (1987). Protein kinase C activation selectively augments a stretch-induced, calcium-dependent tone in vascular smooth muscle. J Pharmacol Exp Ther 242, 566-572. Laher, I., van Breemen, C., and Bevan, J. A. (1988). Stretch-dependent calcium uptake associated with myogenic tone in rabbit facial vein. Circ Res 63, 669-672. Laher, I., Vorkapic, P., Dowd, A. L., and Bevan, J. A. (1989). Protein kinase C potentiates stretch-induced cerebral artery tone by increasing intracellular sensitivity to Ca2+. Biochem Biophys Res Commun 165, 312-318. Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., and Hultgren, S. J. (1997). Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276, 607-611. Langley, J. N., and Anderson, H. K. (1895). The Innervation of the Pelvic and adjoining Viscera: Part II. The Bladder. Part III. The External Generative Organs. Part IV. The Internal Generative Organs. Part V. Position of the Nerve Cells on the Course of the Efferent Nerve Fibres. J Physiol 19, 71-139. Laporte, R., Haeberle, J. R., and Laher, I. (1994). Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylation. J Mol Cell Cardiol 26, 297-302. Le Bouguenec, C., Archambaud, M., and Labigne, A. (1992). Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 30, 1189-1193. Lecci, A., Tramontana, M., Giuliani, S., Criscuoli, M., and Maggi, C. A. (1998). Effect of tachykinin NK2 receptor blockade on detrusor hyperreflexia induced by bacterial toxin in rats. J Urol 160, 206-209. Lee, T., Kim, J., and Sohn, U. (2002). Sphingosylphosphorylcholine-induced contraction of feline ileal smooth muscle cells is mediated by Galphai3 protein and MAPK. Cell Signal 14, 989-997. Lemack, G. E., Burkhard, F., Zimmern, P. E., McConnell, J. D., and Lin, V. K. (1999). Physiologic sequelae of partial infravesical obstruction in the mouse: role of inducible nitric oxide synthase. J Urol 161, 1015-1022. Lemack, G. E., Zimmern, P. E., Vazquez, D., Connell, J. D., and Lin, V. K. (2000). Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase. J Urol 163, 1981-1987. Levendoglu, F., Ugurlu, H., Ozerbil, O. M., Tuncer, I., and Ural, O. (2004). Urethral cultures in patients with spinal cord injury. Spinal Cord 42, 106-109. Levin, R. M., Ruggieri, M. R., and Wein, A. J. (1986). Functional effects of the purinergic innervation of the rabbit urinary bladder. J Pharmacol Exp Ther 236, 452-457. Lin, C. H., Lin, Y. F., Chang, M. C., Wu, C. H., Ho, Y. S., and Lee, H. M. (2001). Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: involvement of a p38 MAP kinase-dependent mechanism. Life Sci 69, 2503-2515. Lincoln, J., Crockett, M., Haven, A. J., and Burnstock, G. (1984). Rat bladder in the early stages of streptozotocin-induced diabetes: adrenergic and cholinergic innervation. Diabetologia 26, 81-87. Liu, S. H., and Lin-Shiau, S. Y. (1997). Enhancement by nitric oxide of neurogenic contraction in the mouse urinary bladder. Naunyn Schmiedebergs Arch Pharmacol 356, 850-852. Liu, S. H., and Lin-Shiau, S. Y. (2000). Protein kinase c regulates purinergic component of neurogenic contractions in mouse bladder. J Urol 164, 1764-1767. Lluel, P., Barras, M., and Palea, S. (2002). Cholinergic and purinergic contribution to the micturition reflex in conscious rats with long-term bladder outlet obstruction. Neurourol Urodyn 21, 142-153. Longhurst, P. A., and Belis, J. A. (1986). Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus. J Pharmacol Exp Ther 238, 773-777. Longhurst, P. A., Kang, J. S., Wein, A. J., and Levin, R. M. (1990). Comparative length-tension relationship of urinary bladder strips from hamsters, rats, guinea-pigs, rabbits and cats. Comp Biochem Physiol A 96, 221-225. Loufrani, L., Lehoux, S., Tedgui, A., Levy, B. I., and Henrion, D. (1999). Stretch induces mitogen-activated protein kinase activation and myogenic tone through 2 distinct pathways. Arterioscler Thromb Vasc Biol 19, 2878-2883. Lowe, V. C., and Noronha-Blob, L. (1991). Effect of extracellular Ca2+ on cholinergic, KCl and phorbol ester-mediated phosphoinositide turnover and guinea pig urinary bladder contraction. Eur J Pharmacol 195, 273-279. Luheshi, G. N., and Zar, M. A. (1991). The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder. Br J Pharmacol 103, 1657-1662. Lundberg, J. O., Ehren, I., Jansson, O., Adolfsson, J., Lundberg, J. M., Weitzberg, E., Alving, K., and Wiklund, N. P. (1996). Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 48, 700-702. Maggi, C. A., Santicioli, P., and Meli, A. (1985). Pharmacological evidence for the existence of two components in the twitch response to field stimulation of detrusor strips from the rat urinary bladder. J Auton Pharmacol 5, 221-229. Malmgren, A., Andersson, K. E., Andersson, P. O., Fovaeus, M., and Sjogren, C. (1990). Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro. J Urol 143, 828-834. Malmgren, A., Uvelius, B., Andersson, K. E., and Andersson, P. O. (1992). Urinary bladder function in rats with hereditary diabetes insipidus; a cystometrical and in vitro evaluation. J Urol 148, 930-934. Malmqvist, U., and Arner, A. (1991). Correlation between isoform composition of the 17 kDa myosin light chain and maximal shortening velocity in smooth muscle. Pflugers Arch 418, 523-530. Mamas, M. A., Reynard, J. M., and Brading, A. F. (2003). Nitric oxide and the lower urinary tract: current concepts, future prospects. Urology 61, 1079-1085. Massett, M. P., Ungvari, Z., Csiszar, A., Kaley, G., and Koller, A. (2002). Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol 283, H2282-2287. Masuda, H., Okuno, T., Suzuki, M., Kihara, K., Goto, M., and Azuma, H. (2002a). Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities in the detrusor and proximal urethra of the rabbit. J Urol 168, 2286-2290. Masuda, H., Tsujii, T., Okuno, T., Kihara, K., Goto, M., and Azuma, H. (2002b). Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract. J Urol 167, 2235-2240. Mehta, P. K., and Griendling, K. K. (2006). Angiotensin II Cell Signaling: Physiological and Pathological Effects in the Cardiovascular System. Am J Physiol Cell Physiol. Meiland, R., Geerlings, S. E., Stolk, R. P., Netten, P. M., Schneeberger, P. M., and Hoepelman, A. I. (2006). Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med 166, 2222-2227. Meininger, G. A., and Davis, M. J. (1992). Cellular mechanisms involved in the vascular myogenic response. Am J Physiol 263, H647-659. Menkes, H., Baraban, J. M., and Snyder, S. H. (1986). Protein kinase C regulates smooth muscle tension in guinea-pig trachea and ileum. Eur J Pharmacol 122, 19-27. Minion, F. C., Abraham, S. N., Beachey, E. H., and Goguen, J. D. (1986). The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol 165, 1033-1036. Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., and Currie, M. G. (1993). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233, 119-125. Mizunoe, Y., Matsumoto, T., Sakumoto, M., Kubo, S., Mochida, O., Sakamoto, Y., and Kumazawa, J. (1997). Renal scarring by mannose-sensitive adhesin of Escherichia coli type 1 pili. Nephron 77, 412-416. Mizutani, T., Akinaga, N., and Takatera, H. (1989). Urinary nitrite in Japanese patients with urinary tract infections. Sci Total Environ 80, 161-165. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142. Moon, A. (2002). Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro. BJU Int 89, 942-949. Morini, G., Kuemmerle, J. F., Impicciatore, M., Grider, J. R., and Makhlouf, G. M. (1993). Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells. J Pharmacol Exp Ther 264, 598-603. Morrison, D. L., Sanghera, J. S., Stewart, J., Sutherland, C., Walsh, M. P., and Pelech, S. L. (1996). Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1. Biochem Cell Biol 74, 549-557. Mulvey, M. A., Lopez-Boado, Y. S., Wilson, C. L., Roth, R., Parks, W. C., Heuser, J., and Hultgren, S. J. (1998). Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494-1497. Mumtaz, F. H., Khan, M. A., Thompson, C. S., Morgan, R. J., and Mikhailidis, D. P. (2000). Nitric oxide in the lower urinary tract: physiological and pathological implications. BJU Int 85, 567-578. Munzel, F., Muhlhauser, U., Zimmermann, W. H., Didie, M., Schneiderbanger, K., Schubert, P., Engmann, S., Eschenhagen, T., and Zolk, O. (2005). Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition. Cardiovasc Res 68, 464-474. Murthy, K. S. (2006). Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68, 345-374. Murthy, K. S., Zhou, H., Grider, J. R., Brautigan, D. L., Eto, M., and Makhlouf, G. M. (2003). Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. Biochem J 374, 145-155. Naik, M. U., Benedikz, E., Hernandez, I., Libien, J., Hrabe, J., Valsamis, M., Dow-Edwards, D., Osman, M., and Sacktor, T. C. (2000). Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol 426, 243-258. Nakayama, K., Obara, K., Tanabe, Y., Saito, M., Ishikawa, T., and Nishizawa, S. (2003). Interactive role of tyrosine kinase, protein kinase C, and Rho/Rho kinase systems in the mechanotransduction of vascular smooth muscles. Biorheology 40, 307-314. Nguyen, H. T., Adam, R. M., Bride, S. H., Park, J. M., Peters, C. A., and Freeman, M. R. (2000). Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells. Am J Physiol Cell Physiol 279, C1155-1167. Nixon, G. F., Iizuka, K., Haystead, C. M., Haystead, T. A., Somlyo, A. P., and Somlyo, A. V. (1995). Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle. J Physiol 487 ( Pt 2), 283-289. North, R. A. (2002). Molecular physiology of P2X receptors. Physiol Rev 82, 1013-1067. Nussler, A. K., and Billiar, T. R. (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54, 171-178. Nys, S., van Merode, T., Bartelds, A. I., and Stobberingh, E. E. (2006). Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 57, 955-958. O'Reilly, B. A., Kosaka, A. H., Chang, T. K., Ford, A. P., Popert, R., and McMahon, S. B. (2001). A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction. BJU Int 87, 617-622. O'Reilly, B. A., Kosaka, A. H., Knight, G. F., Chang, T. K., Ford, A. P., Rymer, J. M., Popert, R., Burnstock, G., and McMahon, S. B. (2002). P2X receptors and their role in female idiopathic detrusor instability. J Urol 167, 157-164. Oeckler, R. A., Kaminski, P. M., and Wolin, M. S. (2003). Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92, 23-31. Olsson, L. E., Wheeler, M. A., Sessa, W. C., and Weiss, R. M. (1998). Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder. J Pharmacol Exp Ther 284, 1203-1208. Osol, G., Laher, I., and Cipolla, M. (1991). Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 68, 359-367. Ozawa, H., Chancellor, M. B., Jung, S. Y., Yokoyama, T., Fraser, M. O., Yu, Y., de Groat, W. C., and Yoshimura, N. (1999). Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 162, 2211-2216. Palea, S., Artibani, W., Ostardo, E., Trist, D. G., and Pietra, C. (1993). Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 150, 2007-2012. Palmer, R. M., Ferrige, A. G., and Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526. Palmer, R. M., and Moncada, S. (1989). A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 158, 348-352. Parija, S. C., Raviprakash, V., and Mishra, S. K. (1991). Adenosine- and alpha,beta-methylene ATP-induced differential inhibition of cholinergic and non-cholinergic neurogenic responses in rat urinary bladder. Br J Pharmacol 102, 396-400. Paro, M., Prashar, A., Prosdocimi, M., Cherian, P. V., Fiori, M. G., and Sima, A. A. (1994). Urinary bladder dysfunction in the BB/W diabetic rat: effect of ganglioside treatment on functional and structural alterations. J Urol 151, 781-786. Paskaloglu, K., Sener, G., and Ayangolu-Dulger, G. (2004). Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 499, 345-354. Patterson, J. E., and Andriole, V. T. (1995). Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 9, 25-51. Patterson, J. E., and Andriole, V. T. (1997). Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 11, 735-750. Pitre, D. A., Ma, T., Wallace, L. J., and Bauer, J. A. (2002). Time-dependent urinary bladder remodeling in the streptozotocin-induced diabetic rat model. Acta Diabetol 39, 23-27. Pitre, D. A., Seifert, J. L., and Bauer, J. A. (2001). Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy. Neurosci Lett 303, 67-71. Poladia, D. P., and Bauer, J. A. (2004). Oxidant driven signaling pathways during diabetes: role of Rac1 and modulation of protein kinase activity in mouse urinary bladder. Biochimie 86, 543-551. Poljakovic, M., and Persson, K. (2003). Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am J Physiol Renal Physiol 284, F22-31. Poljakovic, M., Svensson, M. L., Svanborg, C., Johansson, K., Larsson, B., and Persson, K. (2001). Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney. Kidney Int 59, 893-904. Ralevic, V., and Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50, 413-492. Rapoport, R. M., Draznin, M. B., and Murad, F. (1983). Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306, 174-176. Rhee, S. G. (2001). Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70, 281-312. Ribera, M. C., Pascual, R., Orozco, D., Perez Barba, C., Pedrera, V., and Gil, V. (2006). Incidence and risk factors associated with urinary tract infection in diabetic patients with and without asymptomatic bacteriuria. Eur J Clin Microbiol Infect Dis 25, 389-393. Rojas, A., Caveda, L., Romay, C., Lopez, E., Valdes, S., Padron, J., Glaria, L., Martinez, O., and Delgado, R. (1996). Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages. Biochem Biophys Res Commun 225, 358-362. Sanders, K. M. (2001). Invited review: mechanisms of calcium handling in smooth muscles. J Appl Physiol 91, 1438-1449. Sanders, L. C., Matsumura, F., Bokoch, G. M., and de Lanerolle, P. (1999). Inhibition of myosin light chain kinase by p21-activated kinase. Science 283, 2083-2085. Sasaki, K., Chancellor, M. B., Phelan, M. W., Yokoyama, T., Fraser, M. O., Seki, S., Kubo, K., Kumon, H., Groat, W. C., and Yoshimura, N. (2002). Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol 168, 1259-1264. Schlager, T. A., Hendley, J. O., Wilson, R. A., Simon, V., and Whittam, T. S. (1999). Correlation of periurethral bacterial flora with bacteriuria and urinary tract infection in children with neurogenic bladder receiving intermittent catheterization. Clin Infect Dis 28, 346-350. Schwarz, N. T., Jung, S. Y., Kalff, J. C., Chancellor, M., and Bauer, A. J. (2002). Bacterial toxin N-formyl-methionyl-leucyl-phenylalanine acutely contracts human and rabbit detrusor through the release of eicosanoids. J Urol 167, 2603-2612. Shaul, P. W., Afshar, S., Gibson, L. L., Sherman, T. S., Kerecman, J. D., Grubb, P. H., Yoder, B. A., and McCurnin, D. C. (2002). Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283, L1192-1199. Shimizu, H., Ito, M., Miyahara, M., Ichikawa, K., Okubo, S., Konishi, T., Naka, M., Tanaka, T., Hirano, K., Hartshorne, D. J., and et al. (1994). Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. J Biol Chem 269, 30407-30411. Shirazi, A., Iizuka, K., Fadden, P., Mosse, C., Somlyo, A. P., Somlyo, A. V., and Haystead, T. A. (1994). Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem 269, 31598-31606. Sibley, G. N. (1984). A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol 354, 431-443. Sigala, S., Mirabella, G., Peroni, A., Pezzotti, G., Simeone, C., Spano, P., and Cunico, S. C. (2002). Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. Urology 60, 719-725. Sjogren, C., Andersson, K. E., Husted, S., Mattiasson, A., and Moller-Madsen, B. (1982). Atropine resistance of transmurally stimulated isolated human bladder muscle. J Urol 128, 1368-1371. Sjuve, R., Arner, A., Li, Z., Mies, B., Paulin, D., Schmittner, M., and Small, J. V. (1998). Mechanical alterations in smooth muscle from mice lacking desmin. J Muscle Res Cell Motil 19, 415-429. Smith, S. D., Wheeler, M. A., Foster, H. E., Jr., and Weiss, R. M. (1996). Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 155, 1432-1435. Smith, S. D., Wheeler, M. A., and Weiss, R. M. (1994). Nitric oxide synthase: an endogenous source of elevated nitrite in infected urine. Kidney Int 45, 586-591. Somlyo, A. P., and Somlyo, A. V. (2002). The sarcoplasmic reticulum: then and now. Novartis Found Symp 246, 258-268; discussion 268-271, 272-256. Somlyo, A. P., and Somlyo, A. V. (2003). Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83, 1325-1358. Sommer, M., Eismann, U., Deuther-Conrad, W., Wendt, T., Mohorn, T., Funfstuck, R., and Stein, G. (2000). Time course of cytokine mRNA expression in kidneys of rats with unilateral ureteral obstruction. Nephron 84, 49-57. Somogyi, G. T., and de Groat, W. C. (1999). Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder. Life Sci 64, 411-418. Stamm, W. E. (2002). Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113 Suppl 1A, 1S-4S. Starer, P., and Libow, L. (1990). Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med 150, 810-813. Stein, P. C., Pham, H., Ito, T., and Parsons, C. L. (1996). Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin. J Urol 155, 1133-1138. Strehlow, M. C., Emond, S. D., Shapiro, N. I., Pelletier, A. J., and Camargo, C. A., Jr. (2006). National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med 48, 326-331, 331 e321-323. Stull, J. T. (1996). Myosin minireview series. J Biol Chem 271, 15849. Svanborg, C., Bergsten, G., Fischer, H., Frendeus, B., Godaly, G., Gustafsson, E., Hang, L., Hedlund, M., Karpman, D., Lundstedt, A. C., Samuelsson, M., Samuelsson, P., Svensson, M., and Wullt, B. (2001). The 'innate' host response protects and damages the infected urinary tract. Ann Med 33, 563-570. Swiatkowski, S., Seifert, H. H., Steinhoff, C., Prior, A., Thievessen, I., Schliess, F., and Schulz, W. A. (2003). Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res 282, 48-57. Tagliani, M., Candura, S. M., Di Nucci, A., Franceschetti, G. P., D'Agostino, G., Ricotti, P., Fiori, E., and Tonini, M. (1997). A re-appraisal of the nature of the atropine-resistant contraction to electrical field stimulation in the human isolated detrusor muscle. Naunyn Schmiedebergs Arch Pharmacol 356, 750-755. Tanaka, C., and Nishizuka, Y. (1994). The protein kinase C family for neuronal signaling. Annu Rev Neurosci 17, 551-567. Tomlinson, D. R. (1999). Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42, 1271-1281. Twaij, M. (2000). Urinary tract infection in children: a review of its pathogenesis and risk factors. J R Soc Health 120, 220-226. Ueda, T., Yoshimura, N., and Yoshida, O. (1997). Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 157, 580-584. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M., and Narumiya, S. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994. Uvelius, B. (1977). Influence of muscle length on the force-velocity relation of K+-contractures in smooth muscle from rabbit urinary bladder. Acta Physiol Scand 101, 270-277. Uvelius, B. (2001). Length-tension relations of in vitro urinary bladder smooth muscle strips. J Pharmacol Toxicol Methods 45, 87-90. Uvelius, B., and Gabella, G. (1980). Relation between cell length and force production in urinary bladder smooth muscle. Acta Physiol Scand 110, 357-365. Vallance, P., and Moncada, S. (1994). Nitric oxide--from mediator to medicines. J R Coll Physicians Lond 28, 209-219. VanBavel, E., Wesselman, J. P., and Spaan, J. A. (1998). Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries. Circ Res 82, 210-220. Walsh, M. P. (1991). The Ayerst Award Lecture 1990. Calcium-dependent mechanisms of regulation of smooth muscle contraction. Biochem Cell Biol 69, 771-800. Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., and Stamm, W. E. (1999). Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29, 745-758. Weng, T. I., Chen, W. J., and Liu, S. H. (2005). Bladder instillation of Escherichia coli lipopolysaccharide alters the muscle contractions in rat urinary bladder via a protein kinase C-related pathway. Toxicol Appl Pharmacol 208, 163-169. Wheeler, M. A., Pontari, M., Dokita, S., Nishimoto, T., Cho, Y. H., Hong, K. W., and Weiss, R. M. (1997). Age-dependent changes in particulate and soluble guanylyl cyclase activities in urinary tract smooth muscle. Mol Cell Biochem 169, 115-124. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L. (1999). Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79, 143-180. Wong, A., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Schinzel, R., Wiesinger, H., Riederer, P., and Munch, G. (2001). Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur J Neurosci 14, 1961-1967. Wu, C., Bayliss, M., Newgreen, D., Mundy, A. R., and Fry, C. H. (1999). A comparison of the mode of action of ATP and carbachol on isolated human detrusor smooth muscle. J Urol 162, 1840-1847. Wu, C., Sui, G., and Fry, C. H. (2002). The role of the L-type Ca(2+) channel in refilling functional intracellular Ca(2+) stores in guinea-pig detrusor smooth muscle. J Physiol 538, 357-369. Wu, X. R., Sun, T. T., and Medina, J. J. (1996). In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A 93, 9630-9635. Wullt, B., Bergsten, G., Connell, H., Rollano, P., Gebratsedik, N., Hang, L., and Svanborg, C. (2001). P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 3, 255-264. Xiao, D., Buchholz, J. N., and Zhang, L. (2006). Pregnancy attenuates uterine artery pressure-dependent vascular tone: role of PKC/ERK pathway. Am J Physiol Heart Circ Physiol 290, H2337-2343. Xiao, D., Longo, L. D., and Zhang, L. (2005). Alpha1-adrenoceptor-mediated phosphorylation of MYPT-1 and CPI-17 in the uterine artery: role of ERK/PKC. Am J Physiol Heart Circ Physiol 288, H2828-2835. Xiao, D., Pearce, W. J., Longo, L. D., and Zhang, L. (2004). ERK-mediated uterine artery contraction: role of thick and thin filament regulatory pathways. Am J Physiol Heart Circ Physiol 286, H1615-1622. Xiao, D., and Zhang, L. (2002). ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy. Am J Physiol Heart Circ Physiol 282, H292-300. Yamaguchi, O., Shishido, K., Tamura, K., Ogawa, T., Fujimura, T., and Ohtsuka, M. (1996). Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle. J Urol 156, 1208-1213. Yamamoto, S., Tsukamoto, T., Terai, A., Kurazono, H., Takeda, Y., and Yoshida, O. (1997). Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol 157, 1127-1129. Yang, C. M., Chien, C. S., Hsiao, L. D., Luo, S. F., and Wang, C. C. (2002). Interleukin-1beta-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-kappaB pathways in canine tracheal smooth muscle cells. Cell Signal 14, 899-911. Yoshida, M., Nishi, K., Machida, J., Sakiyama, H., Ikeda, K., and Ueda, S. (1992). Effects of phorbol ester on lower urinary tract smooth muscles in rabbits. Eur J Pharmacol 222, 205-211.; en-US; http://ntur.lib.ntu.edu.tw/handle/246246/63661Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/63661/1/ntu-96-D90447002-1.pdfTest

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/63661Test
http://ntur.lib.ntu.edu.tw/bitstream/246246/63661/1/ntu-96-D90447002-1.pdfTest

المؤلفون: 鄭博文, Cheng, Po-Wen

المساهمون: 蕭水銀, 臺灣大學：毒理學研究所

مصطلحات موضوعية: 聽性腦幹反應, 鈣-腺三磷酸酵素, 溫差測驗, 順-雙氨雙氯鉑, 耳蝸毒性, D型甲硫胺酸, 脂質過氧化物, 鈉鉀-腺三磷酸酵素, 一氧化氮, 噪音, 氧化壓力, 暫時聽閾值變動, 前庭眼反射, 前庭毒性, Auditory brainstem response, Ca2+-ATPase, Caloric test, Cisplatin, Cochleotoxicity, D-methionine, Lipid peroxidation, Na+, K+-ATPase, Nitric oxide, Noise, Oxidative stress, Temporary threshold shift, Vestibulo-ocular reflex, Vestibulotoxicity

العلاقة: Agrup, C., Bagger-Sjoback, D., Fryckstedt, J. (1999). Presence of plasma membrane-bound Ca2+-ATPase in the secretory epithelia of the inner ear. Acta Otolaryngol. 119, 437-445. Assad, J. A., Shepherd, G. M., Corey, D. P. (1991). Tip-link integrity and mechanical transduction in vertebrate hair cells. Neuron 7, 985-994. Baloh, R. W., Jenkins, H. A., Honrubia, V., Yee, R. D., Lau, C. G. (1979). Visual-vestibular interaction and cerebellar atrophy. Neurology 29, 116-119. Barmack, N. H., (1981). A comparison of the horizontal and vertical vestibulo-ocular reflexes of the rabbit. J. Physiol. 314, 547-564. Barron, S. E., Daigneault, E. A. (1987). Effect of cisplatin on hair cell morphology and lateral wall Na, K-ATPase activity. Hear. Res. 26, 131-137. Berry, J. M., Jacobs, C., Sikic, B., Jalsey, J., Borch, R. F. (1990). Modification of cisplatin toxicity with diethyldithiocarbamate. J. Clin. Oncol. 8, 1585-1590. Black, F. O., Myers, E. N., Schramm, V. L., Johnson, J., Sigler, B., Thearle, P. B., Burns, D. S. (1982). Cisplatin vestibular ototoxicity: preliminary report. Laryngoscope 92, 1363-1368. Blumenreich, M. S., Woodcock, T. M., Jones, M., Richman, S. P., Gentile,P. S., Kubota, T. T., Allegra, J. C. (1985). High-dose cisplatin in patients with advanced malignancies. Cancer 55, 1118-1122. Borg, E., Canlon, B., Engstrom, B. (1995). Noise-induced hearing loss. Literature review and experiments in rabbits. Morphological and electrophysiological features, exposure parameters and temporal factors, variability and interactions. Scand. Audiol. Suppl., 40, 1-147. Bosher, S. K. (1980). The effects of inhibition of the strial Na+, K+-activated ATPase by perilymphatic ouabain in the guinea pig. Acta Otolaryngol. 90, 219-229. Brady, H. R., Kone, B. C., Stromski, M. E., Zeidel, M. L., Giebisch, G., Gullans, S. R. (1990). Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am. J. Physiol. 258, 1181-1187. Campbell, K. C., Rybak, L. P., Meech, R. P., Hughes, L. (1996). D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear. Res. 102, 90-98. Campbell, K. C., Meech, R. P., Rybak, L. P., Hughes, L. F. (1999). D-Methionine protects against cisplatin damage to the stria vascularis. Hear. Res. 138, 13-28. Campbell, K. C., Meech, R. P., Rybak, L. P., Hughes, L. F. (2003). The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J. Am. Acad. Audiol. 14, 144-156. Canlon, B., Schacht, J. (1983). Acoustic stimulation alters deoxyglucose uptake in the mouse cochlea and inferior colliculus. Hear. Res., 10, 217-226. Cassandro, E., Sequino, L., Mondola, P., Attanasio, G., Barbara, M., Filipo, R. (2003). Effect of superoxide dismutase and allopurinol on impulse noise-exposed guinea pigs--electrophysiological and biochemical study. Acta Otolaryngol., 123, 802-807. Chan, M. M., Fong, D., Soprano, K. J., Holmes, W. F., Heverling, H. (2003). Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J. Cell Physiol., 194: 63-70. Chen, Y. S., Tseng, F. Y., Liu, T. C., Lin-Shiau, S. Y., Hsu, C. J. (2005). Involvement of nitric oxide generation in noise-induced temporary threshold shift in guinea pigs. Hear. Res., 203, 94-100. Chen, Z., Ulfendahl, M., Ruan, R., Tan, L., Duan, M. (2004). Protection of auditory function against noise trauma with local caroverine administration in guinea pigs. Hear. Res., 197, 131-136. Cheng, P. W., Kaga, K., Koyama, S., Kondo, K. (2001). Temporal bone histopathology after treatment by a large amount of cisplatin: a case study. Otolaryngol. Head Neck Surg. 125, 411-413. Cheng, P. W., Liu, S. H., Hsu, C. J., Lin-Shiau, S. Y. (2005). Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs. Hear. Res. 205, 102-109. Cheng, P. W., Liu, S. H., Young, Y. H., Lin-Shiau, S. Y. (2006). d-Methionine attenuated cisplatin-induced vestibulotoxicity through altering ATPase activities and oxidative stress in guinea pigs. Toxicol. Appl. Pharmacol., 215, 228-236. Clerici, W. J., DiMartino, D. L., Prasad, M. R. (1995). Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro. Hear. Res. 84, 30-40. Clerici, W. J., Hensley, K., DiMartino, D. L., Butterfield, D. A. (1996). Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 98, 116-124. Clerici, W. J., Yang, L. (1996). Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear. Res., 101, 14–22. Cross, H. J., Tilby, M., Chipman, J. K., Ferry, D. R., Gescher, A. (1996). Effect of quercetin on the genotoxic potential of cisplatin. Int. J. Cancer, 66: 404-408. Crow, J. P., Beckman, J. S. (1995). The role of peroxynitrite in nitric oxide mediated toxicity. Curr. Top. Microbiol. Immunol., 196, 53-73. Curtis, L. M., Garg, L. C., Rarey, K. E. (1997). Ca2+-ATPases in the cochlear duct. Acta Otolaryngol. 117, 553-558. De Lauretis, A., De Capua, B., Barbieri, M. T., Bellussi, L., Passali, D. (1999). ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. Scand. Audiol. 28,139-143. Dieterich, M., Brandt, T. (1995). Vestibulo-ocular reflex. Curr. Opin. Neurol. 8, 83-88. Duan, M. L., Ulfendahl, M., Laurell, G., Counter, A. S., Pyykko, I., Borg, E., et al. (2002). Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Hear. Res., 169, 169-178. Eastman, A. (1986). Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry 25, 3912-3915. Ekborn, A., Laurell, G., Johnstrom, P., Wallin, I., Eksborg, S., Ehrsson, H. (2002). D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear. Res. 165, 53-61. Flock, A., Flock, B., Ulfendahl, M. (1986). Mechanisms of movement in outer hair cells and a possible structural basis. Arch. Otorhinolaryngol. 243, 83–90. Forastiere, A. A., Takasugi, B. J., Baker, S. R., Wolf, G. T. and Kudla-Hatch, V. (1987) High-dose cisplatin in advanced head and neck cancer. Cancer Chemother. Pharmacol. 19, 155-158. Francescato, H. D., Coimbra, T. M., Costa, R. S., Bianchi Mde, L. (2004). Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis. Kidney Blood Press Res. 27, 148-158. Friedman, M. (1999). Chemistry, nutrition, and microbiology of d-amino acids. J. Agric. Food Chem., 347, 3457-3459. Gratton, M. A., Smyth, B. J., Lam, C. F., Boettcher, F. A., Schmiedt, R. A. (1997). Decline in the endocochlear potential corresponds to decreased Na, K-ATPase activity in the lateral wall of quiet-aged gerbils. Hear. Res. 108, 9-16. Guo, Y., Wu, Y., Chen, W., Lin, J. (1994). Endotoxic damage to the stria vascularis: the pathogenesis of sensorineural hearing loss secondary to otitis media. J. Laryngol. Otol. 108, 310-313. Hamernik, R. P., Turrentine, G., Roberto, M., Salvi, R., Henderson, D. (1984). Anatomical correlates of impulse noise-induced mechanical damage in the cochlea. Hear. Res., 13, 229-247. Hartwig, S., Pettersson, U., Stahle, J. (1983). cis-Diamminedichloroplatinum: a cytostatic with an ototoxic effect. ORL J. Otorhinolaryngol. Relat. Spec. 45, 257-261. Hawkins, J. E., Jr. (1971). The role of vasoconstriction in noise-induced hearing loss. Ann. Otol. Rhinol. Laryngol., 80, 903-913. Henriksson, N. G. (1956). Speed of slow component and duration in caloric nystagmus. Acta Otolaryngol. Suppl. 125, 1–29. Hinojosa, R., Riggs, L. C., Strauss, M., Matz, G. J. (1995). Temporal bone histopathology of cisplatin ototoxicity. Am. J. Otol. 16, 731-740. Hofmann, J., Doppler, W., Jakob, A., Maly, K., Posch, L., Uberall, F., Grunicke, H. H. (1988). Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int. J. Cancer 42, 382-388. Hofmann, J., Fiebig, H. H., Winterhalter, B. R., Berger, D. P., Grunicke, H. (1990). Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer 45, 536-539. Hoistad, D. L., Ondrey, F. G., Mutlu, C., Schachern, P. A., Paparella, M. M., Adams, G. L. (1998). Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol. Head Neck Surg. 118, 825-832. Hsu, C. J., Chen, Y. S., Shau, W. Y., Yeh, T. H., Lee, S. Y., Lin-Shiau, S. Y. (2002). Impact of activities of Na(+)-K(+)-ATPase and Ca2(+)-ATPase in the cochlear lateral wall on recovery from noise-induced temporary threshold shift. Ann. Otol. Rhinol. Laryngol., 111, 842-849. Hsu, C. J., Shau, W. Y., Chen, Y. S., Liu, T. C., Lin-Shiau, S. Y. (2000). Activities of Na(+),K(+)-ATPase and Ca(2+)-ATPase in cochlear lateral wall after acoustic trauma. Hear. Res., 142, 203-211. Huang, M. T., Lou, Y. R., Ma, W., Newmark, H. L., Reuhl, K. R., Conney, A. H. (1994). Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res. 54, 5841-5847. Huang, M. T., Newmark, H. L., Frenkel, K. (1997). Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl. 27, 26-34. Huang, M. T., Smart, R. C., Wong, C. Q., Conney, A. H. (1988). Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48, 5941-5946. Hudspeth, A. J. (1985). The cellular basis of hearing: the biophysics of hair cells. Science 230, 745–752. Ichimiya, I., Adams, J. C., Kimura, R. S. (1994). Immunolocalization of Na+, K+-ATPase, Ca++-ATPase, calcium-binding proteins, and carbonic anhydrase in the guinea pig inner ear. Acta Otolaryngol. 114, 167-176. Ito, M. (1993). Neurophysiology of the nodulofloccular system. Rev. Neurol. (Paris) 149, 692-697. Iwano, T., Yamamoto, A., Omori, K., Akayama, M., Kumazawa, T., Tashiro, Y. (1989). Quantitative immunocytochemical localization of Na+, K+-ATPase α-subunit in the lateral wall of rat cochlear duct. J. Histochem. Cytochem. 37, 353-363. Jones, M. M., Basinger, M. A. (1989). Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma. Anticancer Res. 9, 1937-1941. Kavanagh, K. T., Babin, R. W. (1986). Definitions and types of nystagmus and calculations. Ear. Hear. 7, 157-166. Kelloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R., Sigman, C. C. (1994). Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prev. 3, 85-98. Kerr, T. P., Ross, M. D., Ernst, S. A. (1982). Cellular localization of Na+, K+-ATPase in the mammalian cochlear duct: Significance for cochlear fluid balance. Am. J. Otolaryngol. 3, 332-338. Kinsell, L. W., Harper, H. A., Giese, G. K., Margen, S., McCallie D. P. H. JR. (1949). Studies in methionine metabolism. II: fasting plasma methionine levels in normal and hepatopathic individuals in response to daily methionine ingestion. J. Clin. Invest., 28, 1439-1450. Kitsigianis, G. A., O'Leary, D. P., Davis, L. L. (1988a). Vestibular autorotation testing of cisplatin chemotherapy patients. Adv. Otorhinolaryngol. 42, 250-253. Kitsigianis, G. A., O'Leary, D. P., Davis, L. L. (1988b). Active head-movement analysis of cisplatin-induced vestibulotoxicity. Otolaryngol. Head Neck Surg. 98, 82-87. Kobayashi, H., Ohashi, N., Watanabe, Y., Mizukoshi, K. (1987). Clinical features of cisplatin vestibulotoxicity and hearing loss. ORL J. Otorhinolaryngol. Relat. Spec. 49, 67-72. Kopke, R., Bielefeld, E., Liu, J., Zheng, J., Jackson, R., Henderson, D., Coleman, J. K. (2005). Prevention of impulse noise-induced hearing loss with antioxidants. Acta Otolaryngol., 125, 235-243. Kopke, R. D., Coleman, J. K., Liu, J., Campbell, K.C., Riffenburgh, R. H. (2002). Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss. Laryngoscope, 112, 1515-1532. Kopke, R. D., Liu, W., Gabaizadeh, R., Jacono, A., Feghali, J., Spray, D., Garcia, P., Steinman, H., Malgrange, B., Ruben, R. J., Rybak, L., Van de Water, T. R. (1997). Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am. J. Otol. 18, 559-571. Korkina, L. G., Afanas'ev, I. B. (1997). Antioxidant and chelating properties of flavonoids. Adv. Pharmacol. 38, 151-163. Korver, K. D., Rybak, L. P., Whitworth, C., Campbell, K. M. (2002). Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol. Head Neck Surg. 126, 683-689. Kuhlmann, M. K., Horsch, E., Burkhardt, G., Wagner, M., Kohler, H. (1998). Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch. Toxicol. 72, 536-540. Kunchandy, E., Rao, M. N. A. (1990). Oxygen radical scavenging activity of curcumin. Int. J. Pharm. 58, 237–240. Lamson, D. W., Brignall, M. S. (2000). Antioxidants and cancer, part 3: quercetin. Altern. Med. Rev. 5, 196-208. Lanzetta, P. A., Alvarez, L. J., Reinach, P. S., Candia, O. A. (1979). An improved assay for nanomole amounts of inorganic phosphate. Anal. Biochem. 100, 95-97. Laurell G, Teixeira M, Sterkers O, Bagger-Sjoback D, Eksborg S, Lidman O, Ferrary E. (2002). Local administration of antioxidants to the inner ear. Kinetics and distribution (1). Hear. Res. 173, 198-209. Lee, J. E., Nakagawa, T., Kita, T., Kim, T. S., Iguchi, F., Endo, T., Shiga, A., Lee, S. H., Ito, J. (2004). Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis. ORL J. Otorhinolaryngol. Relat. Spec. 66, 111-118. Lehotsky, J., Kaplan, P., Racay, P., Matejovicova, M., Drgova, A., Mezesova, V. (1999). Membrane ion transport systems during oxidative stress in rodent brain: protective effect of stobadine and other antioxidants. Life Sci. 65, 1951-1958. Liberman, M. C., Dodds, L. W. (1987). Acute ultrastructural changes in acoustic trauma: serial-section reconstruction of stereocilia and cuticular plates. Hear. Res., 26, 45-64. Lin, H. C., Kang, B. H., Wong, C. S., Mao, S. P., Wan, F. J. (1999). Systemic administration of D-amphetamine induced a delayed production of nitric oxide in the striatum of rats. Neurosci. Lett. 276, 141-144. Marquis, R. E., Hudspeth, A. J. (1997). Effects of extracellular Ca2+ concentration on hair-bundle stiffness and gating-spring integrity in hair cells. Proc. Natl. Acad. Sci. 94, 11923-11928. Mees, K. (1983). Ultrastructural localization of K+-dependent, ouabain-sensitive NPPase (Na+, K+-ATPase) in the guinea pig inner ear. Acta Otolaryngol. 95, 277-289. Mehta, K., Pantazis, P., McQueen, T., Aggarwal, B. B. (1997). Antiproliferative effect of Curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8, 470-481. Melnick, W. (1991). Human temporary threshold shift (TTS) and damage risk. Journal of the Acoustical Society of America, 90, 147-154. Muldoon, L. L., Pagel, M. A., Kroll, R. A., Brummett, R. E., Doolittle, N. D., Zuhowski, E. G, Egorin, M. J., Neuwelt, E. A. (2000). Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin. Cancer Res. 6, 309-315. Mulroy, M. J., Fromm, R. F., Curtis, S. (1990). Changes in the synaptic region of auditory hair cells during noise-induced temporary threshold shift. Hear. Res., 49, 79-87. Myers, S. F., Blakley, B. W., Schwan, S. (1993). Is cis-platinum vestibulotoxic ? Otolaryngol. Head Neck Surg. 108, 322-328. Nakai, Y., Masutani, H. (1988). Noise-induced vasconstriction in the cochlea. Acta Otolaryngol. Suppl., 447, 23-27. Nakano, S., Gemba, M. (1989). Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn. J. Pharmacol. 50, 87-92. Nakayama, M. (1992). Cisplatin induced vestibular damage. Nippon Jibiinkoka Gakkai Kaiho 95, 81-94. Nakayama, M., Riggs, L. C., Matz, G. J. (1996). Quantitative study of vestibulotoxicity induced by gentamicin or cisplatin in the guinea pig. Laryngoscope 106, 162-167. Nario, K., Kitano, I., Mori, N., Matsunaga, T. (1998). Effect of endoplasmic Ca2+-ATPase inhibitors on cochlear potentials in the guinea-pig. Acta Otolaryngol. 118, 198-205. Navis, I., Premalatha, B. (1999). Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma. Pharmacol. Res. 39, 175–179. Nechay, B. R., Neldon, S. L. (1984). Characteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid. Cancer Treat. Rep. 68, 1135-1141. Nordmann, A. S., Bohne, B. A., Harding, G. W. (2000). Histopathological differences between temporary and permanent threshold shift. Hear. Res., 139, 13-30. Ohinata, Y., Miller, J. M., Altschuler, R. A., Schacht, J. (2000). Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea. Brain Res., 878, 163-173. Ohinata, Y., Miller, J. M., Schacht, J. (2003). Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res., 966, 265-273. Ohinata, Y., Yamasoba, T., Schacht, J., Miller, J. M. (2000). Glutathione limits noise-induced hearing loss. Hear. Res., 146, 28-34. Ohlemiller, K. K., Wright, J. S., Dugan, L. L. (1999). Early elevation of cochlear reactive oxygen species following noise exposure. Audiol. Neurootol., 4, 229-236. Ozols, R. F., Young, R. C. (1985). High-dose cisplatin therapy in ovarian cancer. Semin. Oncol. Suppl. 4, 21-30. Patuzzi, R. (1998). Exponential onset and recovery of temporary threshold shift after loud sound: evidence for long-term inactivation of mechano-electrical transduction channels. Hear. Res., 125, 17-38. Pettorossi, V. E., Bamonte, F., Errico, P., Ongini, E., Draicchio, F., Sabetta, F. (1986). Vestibulo-ocular reflex (VOR) in guinea pigs. Acta Otolaryngol. 101, 378-388. Pitovski, D. Z., Kerr, T. P. (2002). Sodium- and potassium-activated ATPase in the mammalian vestibular system. Hear. Res. 171, 51-65. Pourbakht, A. Yamasoba, T. (2003). Ebselen attenuates cochlear damage caused by acoustic trauma. Hear. Res., 181, 100-108. Pryor, W. A, Jin, X., Squadrito, G. L. (1994). One- and two-electron oxidations of methionine by peroxynitrite. Proc. Natl. Acad. Sci. U. S. A., 91, 11173-11177. Puel, J. L. (1995). Chemical synaptic transmission in the cochlea. Prog. Neurobiol., 47, 449-476. Ravi, R., Rybak, L. P., Somani, S. M. (1991). Relationship of pharmacodynamic effects of cisplatin to the glutathione levels in cochlea, inferior colliculus and kidney. Pharmacologist 33, 217. Ravi, R., Somani, S. M., Rybak, L. P. (1995). Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76, 386-394. Reser, D., Rho, M., Dewan, D., Herbst, L., Li, G., Stupak, H., Zur, K., Romaine, J., Frenz, D., Goldbloom, L., Kopke, R., Arezzo, J., Van De Water, T. (1999). L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity. Neurotoxicology 20, 731-748. Robertson, D. (1983). Functional significance of dendritic swelling after loud sounds in the guinea pig cochlea. Hear. Res., 9, 263-278. Rosenberg, B. (1985). Fundamental studies with cisplatin. Cancer 55, 2303-2315. Ruan, R. S., Leong, S. K., Yeoh, K. H. (1997). Ototoxicity of sodium nitroprusside. Hear. Res., 114, 169-178. Rybak, L. P., Ravi, R., Somani, S. M. (1995). Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam. Appl. Toxicol. 26, 293-300. Rybak, L. P., Husain, K., Evenson, L., Morris, C., Whitworth, C., Somani, S. M. (1997). Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81, 173-179. Saunders, J. C., Dear, S. P., Schneider, M. E. (1985). The anatomical consequences of acoustic injury: A review and tutorial. J. Acoust. Soc. Am., 78, 833-860. Scambia, G., Ranelletti, F. O., Benedetti Panici, P., Piantelli, M., Bonanno, G., De Vincenzo, R., Ferrandina, G., Maggiano, N., Capelli, A., Mancuso, S. (1992). Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II). Gynecol. Oncol. 45, 13-19. Schaefer, S. D., Wright, C. G., Post, J. D., Frenkel, E. P. (1981). Cis-platinum vestibular toxicity. Cancer 47, 857-859. Schuknecht, H. F. (1993). Acoustic trauma. In: Schuknecht, H. F. (Ed). Pathology of the Ear, 2nd edn. Lea and Febiger, Philadelphia, PA, pp. 289-294. Schulte, B. A. (1993). Immunohistochemical localization of intracellular Ca-ATPase in outer hair cells, neurons and fibrocytes in the adult and developing inner ear. Hear. Res. 65, 262-273. Schulte, B. A., Adams, J. C. (1989). Distribution of immunoreactive Na+, K+-ATPase in gerbil cochlea. J. Histochem. Cytochem. 37, 127-134. Schulte, B. A., Schmiedt, R. A. (1992). Lateral wall Na, K-ATPase and endocochlear potentials decline with age in quiet-reared gerbils. Hear. Res. 61, 35-46. Schweitzer, V. G., Rarey, K. E., Dolan, D. F., Abrams, G. E., Sheridan, C. (1986). Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9). Laryngoscope 96, 959-974. Schweitzer, V. G. (1993). Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents. Laryngoscope 103, 1-52. Seidman, M. D., Shivapuja, B. G., Quirk, W. S. (1993). The protective effects of allopurinol and superoxide dismutase on noise-induced cochlear damage. Otolaryngol Head Neck Surg, 109, 1052-1056. Sergi, B., Ferraresi, A., Troiani, D., Paludetti, G., Fetoni, A. R. (2003). Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear. Res. 182, 56-64. Sergi, B., Fetoni, A. R., Ferraresi, A., Troiani, D., Azzena, G. B., Paludetti, G., Maurizi, M. (2004). The role of antioxidants in protection from ototoxic drugs. Acta Otolaryngol. Suppl. 552, 42-45. Sha, S. H., Schacht, J. (2000). Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear. Res., 142, 34-40. Sharpe, J. A., Goldberg, H. J., Lo, A. W., Herishanu, Y. O. (1981). Visual-vestibular interaction in multiple sclerosis. Neurology 31, 427-433. Shi, X., Nuttall, A. L. (2003). Upregulated iNOS and oxidative damage to the cochlear stria vascularis due to noise stress. Brain Res., 967, 1-10. Shoji, F., Yamasoba, T., Magal, E., Dolan, D. F., Altschuler, R. A., Miller, J. M. (2000). Glial cell line-derived neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear. Res., 142, 41-55. Sie, K. C., Norton, S. J. (1997). Changes in otoacoustic emissions and auditory brain stem response after cis-platinum exposure in gerbils. Otolaryngol. Head Neck Surg. 116, 585-592. Smith, M. A., Crawford, J. D. (1998). Neural control of rotational kinematics within realistic vestibuloocular coordinate systems. J. Neurophysiol. 80, 2295-2315. Soszynski, M., Filipiak, A., Bartosz, G., Gebicki, J. M. (1996). Effect of amino acid peroxides on the erythrocyte. Free Radical Biology & Medicine, 20, 45-51. Spoendlin, H. (1976). Anatomical changes following various noise exposures. In: Henderson, D., Hamernik, R. P., Dosanjh, D. S., and Mills, J. H. (Eds.), Effects of Noise on Hearing. Raven Press, New York, pp. 69-89. Stevens, D. M., Dutka, A. J., Synder, J. E. (1995). Vestibulo-ocular reflex gain as a measure of vestibular function in guinea pigs while in a recompression chamber: Apparatus design and effects of nitrogen narcosis. Am. J. Otol. 16, 360–364. Stewart, D. J., Verma, S., Maroun, J. A. (1987). Phase I study of the combination of disulfiram with cisplatin. Am. J. Clin. Oncol. 10, 517-519. Stopp, P. (1982). The effect of moderate-intensity noise on cochlear potentials and structure. In: Hamernik, R. P., Henderson, D., Salvi, R. (Eds.), New Perspectives on Noise-Induced Hearing Loss. Raven Press, New York, pp. 331-343. Stoter, G., Koopman, A., Vendrik, C. P., Struyvenberg, A., Sleyfer, D. T., Willemse, P. H., Schraffordt Koops, H., van Oasterom, A. T., ten Bokkel Huinink, W. W., Pinedo, H. M. (1989). Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine and bleomycin. J. Clin. Oncol. 7, 1099-1104. Strauss, M., Towfighi, J., Lord, S., Lipton, A., Harvey, H. A., Brown, B. (1983). Cis-platinum ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope 93, 1554-1559. Tay, L. K., Bregman, C. L., Masters, B. A., Williams, P. D. (1988). Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res. 48, 2538-2543. Thomas Dickey, D., Muldoon, L. L., Kraemer, D. F., Neuwelt, E. A. (2004). Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear. Res. 193, 25-30. Van Benthem, P. P. G., Klis, S. F. L., Albers, F. W. J., de Wildt, D. J., Veldman, J. E., Huizing, E. H., Smoorenburg, G. F. (1994). The effect of nimodipine on cochlear potentials and Na+/K+-ATPase activity in normal and hydropic cochleas of the albino guinea pig. Hear. Res. 77, 9-18. Vibert, N. D., Waele, C., Escudero, M., Vidal, P. P. (1993). The horizontal vestibulo-ocular reflex in the hemilabyrinthectomized guinea-pig. Exp.Brain Res. 97, 263–273. Wang, J., Dib, M., Lenoir, M., Vago, P., Eybalin, M., Hameg, A., Pujol, R., Puel, J. L. (2002). Riluzole rescues cochlear sensory cells from acoustic trauma in the guinea-pig. Neuroscience, 111, 635-648. Wangemann, P. (1995). Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cells. Hear. Res. 90, 149-157. Wangemann, P. (2002). K+ cycling and the endocochlear potential. Hear. Res. 165, 1-9. Watanabe, K., Hess, A., Bloch, W., Michel, O. (2000). Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin. Anticancer Drugs 11, 29-32. Watanabe, K., Jinnouchi, K., Baba, S., Yagi, T. (2001 a). Induction of apoptotic pathway in the vestibule of cisplatin (CDDP)-treated guinea pigs. Anticancer Res. 21, 3929-3932. Watanabe, K., Jinnouchi, K., Yagi, T. (2001 b). Detection of single-stranded DNA (ssDNA) in the vestibule of guinea pigs after the application of cisplatinum (CDDP). Anticancer Res. 21, 1135-1138. Weatherly, R. A., Owens, J. J., Catlin, F. I., Mahoney, D. H. (1991). cis-platinum ototoxicity in children. Laryngoscope 101, 917-924. Wright, C. G., Schaefer, S. D. (1982). Inner ear histopathology in patients treated with cis-platinum. Laryngoscope 92, 1408-1413. Yamasoba, T., Schacht, J., Shoji, F., Miller, J. M. (1999). Attenuation of cochlear damage from noise trauma by an iron chelator, a free radical scavenger and glial cell line-derived neurotrophic factor in vivo. Brain Res., 815, 317-325. Yoshihara, T., Igarashi, M. (1987). Cytochemical localization of Ca2+-ATPase activity in the lateral cochlear wall of the guinea pig. Arch. Otorhinolaryngol. 243, 395-400. Yoshihara, T., Usami, S., Igarashi, M., Fermin, C. D. (1987). Ultracytochemical study of ouabain-sensitive, potassium-dependent p-nitrophenylphosphatase activity in the inner ear of the squirrel monkey. Acta Otolaryngol. 103, 161-169. Young, Y. H., Nomura, Y., Okuno, T., Hara, M. (1991). Clip electrode method for recording eye movements in experimental animals. Eur. Arch. Otorhinolaryngol. 248, 331-334. Young, Y. H., Chuu, J. J., Liu, S. H., Lin-Shiau, S.Y. (2002). Neurotoxic mechanism of cinnabar and mercuric sulfide on the vestibulo-ocular reflex system of guinea pigs. Toxicol. Sci. 67, 256-263. Zhang, M., Liu, W., Ding, D., Salvi, R. (2003). Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 120, 191-205.; en-US; http://ntur.lib.ntu.edu.tw/handle/246246/63657Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/63657Test